Structure-based designed herbicide resistant products

FIELD OF THE INVENTION
This invention pertains to structure-based modelling and design of variants of acetohydroxy acid synthase (AHAS) that are resistant to imidazolinones and other herbicides, the AHAS inhibiting herbicides, AHAS variants themselves, DNA encoding these variants, plants expressing these variants, and methods of weed management.
BACKGROUND OF THE INVENTION
Acetohydroxy acid synthase (AHAS) is an enzyme that catalyzes the initial step in the biosynthesis of isoleucine, leucine, and valine in bacteria, yeast, and plants. For example, the mature AHAS from Zea Mays is approximately a 599-amino acid protein that is localized in the chloroplast (see FIG. 1). The enzyme utilizes thiamine pyrophosphate (TPP) and flavin adenine dinucleotide (FAD) as cofactors and pyruvate as a substrate to form acetolactate. The enzyme also catalyzes the condensation of pyruvate and 2-ketobutyrate to form acetohydroxybutyrate. AHAS is also known as acetolactate synthase or acetolactate pyruvate lyase (carboxylating), and is designated EC 4.1.3.18. The active enzyme is probably at least a homodimer. Ibdah et al. (Protein Science, 3:479-S, 1994), in an abstract, disclose one model for the active site of AHAS.
A variety of herbicides including imidazolinone compounds such as imazethapyr (PURSUIT.RTM.--American Cyanamid Company--Wayne, N.J.), sulfonylurea-based compounds such as sulfometuron methyl (OUST.RTM.--E.I. du Pont de Nemours and Company--Wilmington, Del.), triazolopyrimidine sulfonamides (Broadstrike.TM.--Dow Elanco; see Gerwick, et al., Pestic. Sci. 29:357-364, 1990), sulfamoylureas (Rodaway et al., Mechanisms of Selectively of Ac 322,140 in Paddy Rice, Wheat and Barley, Proceedings of the Brighton Crop Protection Conference--Weeds, 1993), pyrimidyl-oxy-benzoic acids (STABLE.RTM.--Kumiai Chemical Industry Company, E.I. du Pont de Nemours and Company; see, The Pesticide Manual 10th Ed. pp. 888-889, Clive Tomlin, Ed., British Crop Protection Council, 49 Downing Street, Farmham, Surrey G49 7PH, UNITED KINGDOM), and sulfonylcarboximides (Alvarado et al., U.S. Pat. No. 4,883,914) act by inhibiting AHAS enzymatic activity. (See, Chaleff et al., Science 224:1443, 1984; LaRossa et al., J.Biol. Chem. 259:8753, 1984; Ray, Plant Physiol. 75:827, 11984; Shaner et al., Plant Physiol. 76:545, 1984). These herbicides are highly effective and environmentally benign. Their use in agriculture, however, is limited by their lack of selectivity, since crops as well as undesirable weeds are sensitive to the phytotoxic effects of these herbicides.
Bedbrook et al., U.S. Pat. Nos. 5,013,659, 5,141,870, and 5,378,824, disclose several sulfonylurea resistant AHAS variants. However, these variants were either obtained by mutagenizing plants, seeds, or cells and selecting for herbicide-resistant mutants, or were derived from such mutants. This approach is unpredictable in that it relies (at least initially) on the random chance introduction of a relevant mutation, rather than a rational design approach based on a structural model of the target protein.
Thus, there is still a need in the art for methods and compositions that provide selective wide spectrum and/or specific herbicide resistance in cultivated crops. The present inventors have discovered that selective herbicide resistant variant forms of AHAS and plants containing the same can be prepared by structure-based modelling of AHAS against pyruvate oxidase (POX), identifying an herbicide binding pocket or pockets on the AHAS model, and designing specific mutations that alter the affinity of the herbicide for the binding pocket. These variants and plants are not inhibited or killed by one or more classes of herbicides and retain sufficient AHAS enzymatic activity to support crop growth.

BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is an illustration of a 600 amino acid sequence (SEQ ID NO:1) corresponding to the approximately 599 amino acid sequence of acetohydroxy acid synthase (AHAS) from Zea Mays which is given as an example of a plant AHAS enzyme. The sequence does not include a transit sequence, and the extra glycine is vestigial from a thrombin cleavage site. Residues Met53, Arg128, and Phe135 are shown in bold.
FIG. 2 is an illustration of the alignment of the sequence of maize AHAS and pyruvate oxidase (POX) (SEQ ID NO:2) from Lactobacillus planarum.
FIG. 3 is a schematic representation of the secondary structure of an AHAS subunit. Regular secondary structure elements, .alpha.-helices and .beta.-sheets, are depicted as circles and ellipses, respectively, and are numbered separately for each of the three domains within a subunit. Loops and coiled regions are represented by black lines, with numbers representing the approximate beginnings and ends of the elements. The locations of cofactor binding sites and known mutation sites are indicated by octahedrons and stars, respectively.
FIG. 4 is an illustration of a computer-generated model of the active site of maize AHAS with imazethapyr (PURSUIT.RTM. herbicide) modeled into the binding pocket.
FIG. 5 is an illustration of the homology among AHAS amino acid sequences derived from different plant species. pAC 751 (SEQ ID NO:3) is maize als 2 AHAS isozyme as expressed from the pAC 751 E. Coli expression vector as in FIG. 1; Maize als 2 (SEQ ID NO:4) is the maize als 2 AHAS isozyme; Maize als 1 (SEQ ID NO:5) is the maize als 1 AHAS isozyme; Tobac 1 (SEQ ID NO:6) is the tobacco AHAS SuRA isozyme; Tobac 2 (SEQ ID NO:7) is the tobacco AHAS SuRB isozyme; Athcsr 12 (SEQ ID NO:8) is the Arabidopsis thaliana Csr 1.2 AHAS gene; Bnaal 3 (SEQ ID NO:9) is the Brassica napus AHAS III isozyme; and Bnaal 2 (SEQ ID NO:10) is the Brassica napus AHAS II isozyme.
pAC 751 and Maize als 2 are identical genes except that Maize als 2 starts at the beginning of the transit sequence and pAC 751 starts at the putative mature N-terminal site with an additional glycine at the N-terminal due to the thrombin recognition sequence in the pGEX-2T expression vector. The N-terminal glycine is not a natural amino acid at that position.
Amino acid sequence alignments of the AHAS proteins were generated by PILEUP (GCG Package--Genetics Computer Group, Inc.,--University Research Park Madison--Wis.). The consensus sequence was generated by PRETTY GCG Package.
FIG. 6 is a photographic illustration of an SDS-polyacrylamide gel stained for protein showing purification of maize AHAS. The lanes contain (from left to right): A, Molecular weight markers; B, Crude E. coli cell extract; C, Glutathione-agarose affinity purified preparation; D, Thrombin digest of the affinity purified preparation; E, Second pass through glutathione-agarose column and Sephacryl S-100 gel filtration.
FIG. 7 is a graphic illustration of the results of in vitro assays of the enzymatic activity of wild-type and mutant AHAS proteins in the absence and in the presence of increasing concentrations of imazethapyr (PURSUIT.RTM. herbicide). The Y axis represents the % of activity of the mutant enzyme, wherein the 100% value is measured in the absence of inhibitor.
FIG. 8 is a graphic illustration of the results of in vitro assays of the enzymatic activity of wild-type and mutant AHAS proteins in the absence and presence of increasing concentrations of sulfometuron methyl (OUST.RTM. herbicide). The Y axis represents the % of activity of the mutant enzyme, wherein the 100% value is measured in the absence of inhibitor.
FIG. 9 is a graphic illustration of in vitro assays of the enzymatic activity of wild-type Arabidopsis AHAS protein and the Met125Ile mutant Arabidopsis AHAS protein in the absence and presence of increasing concentrations of imazethapyr (PURSUIT.RTM. herbicide) and sulfometuron methyl (OUST.RTM. herbicide). The Y axis represents the % activity of the mutant enzyme, wherein the 100% value is measured in the absence of inhibitor.
FIG. 10 is a graphic illustration of in vitro assays of the enzymatic activity of wild-typeArabidopsis AHAS protein and Arg200Glu mutant Arabidopsis AHAS protein in the absence and presence of increasing concentrations of imazethapyr (PURSUIT.RTM. herbicide) and sulfometuron methyl (OUST.RTM. herbicide). The Y axis represents the % activity of the mutant enzyme, wherein the 100% value is measured in the absence of inhibitor.

SUMMARY OF THE INVENTION
The present invention provides a structure-based modelling method for the production of herbicide resistant AHAS variant protein. The method includes:
(a) aligning a target AHAS protein on pyruvate oxidase template or an AHAS modelling equivalent thereof to derive the three-dimensional structure of the target AHAS protein;
(b) modelling one or more herbicides into the three-dimensional structure to localize an herbicide binding pocket in the target AHAS protein;
(c) selecting as a target for a mutation, at least one amino acid position in the target AHAS protein, wherein the mutation alters the affinity of at least one herbicide for the binding pocket;
(d) mutating DNA encoding the target AHAS protein to produce a mutated DNA encoding a variant AHAS containing the mutation, such as, for example, at least one different amino acid, at the position; and
(e) expressing the mutated DNA in a first cell, under conditions in which the variant AHAS containing the mutation, such as, for example, the different amino acid(s), at the position is produced.
The method further may include:
(f) expressing DNA encoding wild-type AHAS protein parallel in a second cell;
(g) purifying the wild-type and the variant AHAS proteins from the cells;
(h) assaying the wild-type and the variant AHAS proteins for catalytic activity in conversion of pyruvate to acetolactate or in the condensation of pyruvate and 2-ketobutyrate to form acetohydroxybutyrate, in the absence and in the presence of the herbicide; and
(i) repeating steps (c)-(h), wherein the DNA encoding the AHAS variant of step (e) is used as the AHAS-encoding DNA in step (c) until a first herbicide resistant AHAS variant protein is identified having:
(i) in the absence of the at least one herbicide,
(a) catalytic activity alone sufficient to maintain the viability of a cell in which it is expressed; or
(b) catalytic activity in combination with any herbicide resistant AHAS variant protein also expressed in the cell, which may be the same as or different than the first AHAS variant protein, sufficient to maintain the viability of a cell in which it is expressed;
wherein the cell requires AHAS activity for viability; and
(ii) catalytic activity that is more resistant to the at least one herbicide than is wild-type AHAS.
An alternate structure-based modelling method for the production of herbicide resistant AHAS variant protein is also provided. This method includes:
(a) aligning a target AHAS protein on a first AHAS template derived from a polypeptide having the sequence of FIG. 1 or a functional equivalent thereof to derive the three-dimensional structure of the target AHAS protein;
(b) modelling one or more herbicides into the three-dimensional structure to localize an herbicide binding pocket in the target AHAS protein;
(c) selecting as a target for a mutation, at least one amino acid position in the target AHAS protein, wherein the mutation alters the affinity of at least one herbicide for the binding pocket;
(d) mutating DNA encoding the target AHAS protein to produce a mutated DNA encoding a variant AHAS containing the mutation at the position; and
(e) expressing the mutated DNA in a first cell, under conditions in which the variant AHAS containing the mutation at the position is produced.
This method can further include:
(f) expressing DNA encoding wild-type AHAS protein in parallel in a second cell;
(g) purifying the wild-type and the variant AHAS protein from the cells;
(h) assaying the wild-type and the variant AHAS protein for catalytic activity in conversion of pyruvate to acetolactate or in the condensation of pyruvate and 2-ketobutyrate to form acetohydroxybutyrate, in the absence and in the presence of the herbicide; and
(i) repeating steps (c)-(h), wherein the DNA encoding the AHAS variant of step (e) is used as the AHAS-encoding DNA in step (c) until a first herbicide resistant AHAS variant protein is identified having:
(i) in the absence of the at least one herbicide,
(a) catalytic activity alone sufficient to maintain the viability of a cell in which it is expressed; or
(b) catalytic activity in combination with any herbicide resistant AHAS variant protein also expressed in the cell, which may be the same as or different than the first AHAS variant protein, sufficient to maintain the viability of a cell in which it is expressed;
wherein the cell requires AHAS activity for viability; and
(ii) catalytic activity that is more resistant to the at least one herbicide than is wild-type AHAS.
In another alternate embodiment, the method includes:
(a) aligning a target AHAS protein on a first AHAS template having an identified herbicide binding pocket and having the sequence of FIG. 1 or a functional equivalent thereof to derive the three-dimensional structure of the target AHAS protein;
(b) selecting as a target for a mutation, at least one amino acid position in the target AHAS protein, wherein the mutation alters the affinity of at least one herbicide for the binding pocket;
(c) mutating DNA encoding the target AHAS protein to produce a mutated DNA encoding a variant AHAS containing the mutation at the position; and
(d) expressing the mutated DNA in a first cell, under conditions in which the variant AHAS containing the mutation at the position is produced.
This method can further include:
(e) expressing DNA encoding wild-type target AHAS protein in parallel in a second cell;
(f) purifying the wild-type and the variant AHAS protein from the cells;
(g) assaying the wild-type and the variant AHAS protein for catalytic activity in conversion of pyruvate to acetolactate or in the condensation of pyruvate and 2-ketobutyrate to form acetohydroxybutyrate, in the absence and in the presence of the herbicide; and
(h) repeating steps (b)-(g), wherein the DNA encoding the AHAS variant of step (d) is used as the AHAS-encoding DNA in step (b) until a first herbicide resistant AHAS variant protein is identified having:
(i) in the absence of the at least one herbicide,
(a) cata lytic activity alone sufficient to maintain the viability of a cell in which it is expressed; or
(b) catalytic activity in combination with any herbicide resistant AHAS variant protein also expressed in the cell, which may be the same as or different than the first AHAS variant protein, sufficient to maintain the viability of a cell in which it is expressed;
wherein the cell requires AHAS activity for viability; and
(ii) catalytic activity that is more resistant to the at least one herbicide than is wild-type AHAS.
In preferred embodiments of the above methods, the catalytic activity in the absence of the herbicide is at least about 5% and most preferably is more than about 20% of the catalytic activity of the wild-type AHAS. Where the herbicide is an imidazolinone herbicide, the herbicide resistant AHAS variant protein preferably has:
(i) catalytic activity in the absence of the herbicide of more than about 20% of the catalytic activity of the wild-type AHAS;
(ii) catalytic activity that is relatively more resistant to the presence of imidazolinone herbicides compared to wild-type AHAS; and
(iii) catalytic activity that is relatively more sensitive to the presence of sulfonylurea herbicides compared to imidazolinone herbicides.
The present invention further provides isolated DNA encoding acetohydroxy acid synthase (AHAS) variant proteins, the variant proteins comprising an AHAS protein modified by:
(i) substitution of at least one different amino acid residue at an amino acid residue of the sequence of FIG. 1 (SEQ ID NO:11) selected from the group consisting of P48, G49, S52, M53, E54, A84, A95, T96, S97, G98, P99, G100, A101, V125, R127, R128, M129, I130, G131, T132, D133, F135, Q136, D186, I187, T259, T260, L261, M262, G263, R276, M277, L278, G279, H281, G282, T283, V284, G300, V301, R302, F303, D304, R306, V307, T308, G309, K310, I311, E312, A313, F314, A315, S316, R317, A318, K319, I320, E329, I330, K332, N333, K334, Q335, T404, G413, V414, G415, Q416, H417, Q418, M419, W420, A421, A422, L434, S435, S436, A437, G438, L439, G440, A441, M442, G443, D467, G468, S469, I471, N473, L477, M479, Q495, H496, L497, G498, M499, V501, Q502, Q504, D505, R506, Y508, K509, A510, N511, N512, A513, H514, T515, S524, H572, Q573, E574, H575, V576, L577, P578, M579, I580, P581, G583, G584, functional equivalents of any of the foregoing, and any combination of any of the foregoing;
(ii) deletion of up to S amino acid residues preceding, or up to 5 amino acid residues following at least one amino acid residue of the sequence of FIG. 1 selected from the group consisting of P48, G49, S52, M53, E54, A84, A95, T96, S97, G98, P99, G100, A101, V125, R127, R128, M129, I130, G131, T132, D133, F135, Q136, D186, I187, T259, T260, L261, M262, G263, R276, M277, L278, G279, H281, G282, T283, V284, G300, V301, R302, F303, D304, R306, V307, T308, G309, K310, I311, E312, A313, F314, A315, S316, R317, A318, K319, I320, E329, I330, K332, N333, K334, Q335, T404, G413, V414, G415, Q416, H417, Q418, M419, W420, A421, A422, L434, S435, S436, A437, G438, L439, G440, A441, M442, G443, D467, G468, S469, L471, N473, L477, M479, Q495, H496, L497, G498, M499, V501, Q502, Q504, D505, R506, Y508, K509, A510, N511, R512, A513, H514, T515, S524, H572, Q573, E574, H575, V576, L577, P578, M579, I580, P581, G583, G584, functional equivalents of any of the foregoing, and any combination of any of the foregoing;
(iii) deletion of at least one amino acid residue or a functional equivalent thereof between Q124 and H150 of the sequence of FIG. 1;
(iv) addition of at least one amino acid residue or a functional equivalent thereof between Q124 and H150 of the sequence of FIG. 1;
(v) deletion of at least one amino acid residue or a functional equivalent thereof between G300 and D324 of the sequence of FIG. 1;
(vi) addition of at least one amino acid residue or a functional equivalent thereof between G300 and D324 of the sequence of FIG. 1; or
(vii) any combination of any of the foregoing.
In this numbering system, residue #2 corresponds to the putative amino terminus of the mature protein, i.e., after removal of a chloroplast targeting peptide.
The above modifications are directed to altering the ability of an herbicide, and preferably an imidazolinone-based herbicide, to inhibit the enzymatic activity of the protein. In a preferred embodiment, the isolated DNA encodes an herbicide-resistant variant of AHAS. Also provided are DNA vectors comprising DNA encoding these AHAS variants, variant AHAS proteins themselves, and cells, grown either in Vivo or in vitro, that express the AHAS variants or comprise these vectors.
In another aspect, the present invention provides a method for conferring herbicide resistance on a cell or cells and particularly a plant cell or cells such as, for example, a seed. An AHAS gene, preferably the Arabidopsis thaliana AHAS gene, is mutated to alter the ability of an herbicide to inhibit the enzymatic activity of the AHAS. The mutant gene is cloned into a compatible expression vector, and the gene is transformed into an herbicide-sensitive cell under conditions in which it is expressed at sufficient levels to confer herbicide resistance on the cell.
Also contemplated are methods for weed control, wherein a crop containing an herbicide resistant AHAS gene according to the present invention is cultivated and treated with a weed-controlling effective amount of the herbicide.
Also disclosed is a structure-based modelling method for the preparation of a first herbicide which inhibits AHAS activity. The method comprises:
(a) aligning a target AHAS protein on pyruvate oxidase template or an AHAS modelling functional equivalent thereof to derive the three-dimensional structure of the target AHAS protein;
(b) modelling a second herbicide having AHAS inhibiting activity into the three-dimensional structure to derive the location, structure, or a combination thereof of an herbicide binding pocket in the target AHAS protein; and
(c) designing a non-peptidic first herbicide which will interact with, and preferably will bind to, an AHAS activity inhibiting effective portion of the binding pocket, wherein the first herbicide inhibits the AHAS activity sufficiently to destroy the viability of a cell which requires AHAS activity for viability.
An alternative structure-based modelling method for the production of a first herbicide which inhibits AHAS activity, is also enclosed. The method comprises:
(a) aligning a target AHAS protein on a first AHAS template derived from a polypeptide having the sequence of FIG. 1 or a functional equivalent thereof, to derive the three-dimensional structure of the target AHAS protein;
(b) modelling a second herbicide having AHAS inhibiting activity into the three-dimensional structure to derive the location, structure, or a combination thereof of an herbicide binding pocket in the target AHAS protein; and
(c) designing a non-peptidic first herbicide which will interact with, and preferably will bind to, an AHAS activity inhibiting effective portion of the binding pocket, wherein the first herbicide inhibits the AHAS activity sufficiently to destroy the viability of a cell which requires AHAS activity for viability.
Preferably in each method, the first herbicide contains at least one functional group that interacts with a functional group of the binding pocket.
DETAILED DESCRIPTION OF THE INVENTION
The present invention encompasses the rational design or structure-based molecular modelling of modified versions of the enzyme AHAS and AHAS inhibiting herbicides. These modified enzymes (AHAS variant proteins) are resistant to the action of herbicides. The present invention also encompasses DNAs that encode these variants, vectors that include these DNAs, the AHAS variant proteins, and cells that express these variants. Additionally provided are methods for producing herbicide resistance in plants by expressing these variants and methods of weed control. The DNA and the AHAS variants of the present invention were discovered in studies that were based on molecular modelling of the structure of AHAS.
Rational Structure-Based Design of AHAS Variants and AHAS Inhibiting Herbicides
Herbicide-resistant variants of AHAS according to the present invention are useful in conferring herbicide resistance in plants and can be designed with the POX model or AHAS modelling functional equivalents thereof, such as, for example, transketolases, carboligases, and pyruvate decarboxylase which have structural features similar to POX and/or AHAS, with an AHAS model such as a model having the sequence of FIG. 1 (SEQ ID NO:1); or with a functional equivalent of the sequence of FIG. 1 including a variant modeled from a previous model. AHAS directed herbicides can be similarly modelled from these templates. A functional equivalent of an AHAS amino acid sequence is a sequence having substantial, i.e., 60-70%, homology, particularly in conserved regions such as, for example, a putative binding pocket. The degree of homology can be determined by simple alignment based on programs known in the art, such as, for example, GAP and PILEUP by GCG. Homology means identical amino acids or conservative substitutions. A functional equivalent of a particular amino acid residue in the AHAS protein of FIG. 1 is an amino acid residue of another AHAS protein which when aligned with the sequence of FIG. 1 by programs known in the art, such as, for example, GAP and PILEUP by GCG, is in the same position as the amino acid residue of FIG. 1.
Rational design steps typically include: (1) alignment of a target AHAS protein with a POX backbone or structure or an AHAS backbone or structure; (2) optionally, and if the AHAS backbone has an identified herbicide binding pocket, modelling one or more herbicides into the three-dimensional structure to localize an herbicide binding pocket in the target protein; (3) selection of a mutation based upon the model; (4) site-directed mutagenesis; and (5) expression and purification of the variants. Additional steps can include (6) assaying of enzymatic properties and (7) evaluation of suitable variants by comparison to the properties of the wild-type AHAS. Each step is discussed separately below.
1. Molecular Modelling
Molecular modelling (and particularly protein homology modelling) techniques can provide an understanding of the structure and activity of a given protein. The structural model of a protein can be determined directly from experimental data such as x-ray crystallography, indirectly by homology modelling or the like, or combinations thereof (See White, et al., Annu. Rev. Biophys. Biomol. Struct., 23:349, 1994). Elucidation of the three-dimensional structure of AHAS provides a basis for the development of a rational scheme for mutation of particular amino acid residues within AHAS that confer herbicide resistance on the polypeptide.
Molecular modelling of the structure of Zea mays AHAS, using as a template the known X-ray crystal structure of related pyruvate oxidase (POX) from Lactobacillus plantarum, provides a three-dimensional model of AHAS structure that is useful for the design of herbicide-resistant AHAS variants or AHAS inhibiting herbicides. This modelling procedure takes advantage of the fact that AHAS and POX share a number of biochemical characteristics and may be derived from a common ancestral gene (Chang et al., J.Bactertiol. 170:3937, 1988).
Because of the high degree of cross-species homology in AHAS the modelled AHAS described herein or functional equivalents thereof can also be used as templates for AHAS variant protein design.
Derivation of one model using interactive molecular graphics and alignments is described in detail below. The three-dimensional AHAS structure that results from this procedure predicts the approximate spatial organization of the active site of the enzyme and of the binding site or pocket of inhibitors such as herbicides including, but not limited to, imidazolinone herbicides. The model is then refined and re-interpreted based on biochemical studies which are also described below.
Protein homology modelling requires the alignment of the primary sequence of the protein under study with a second protein whose crystal structure is known. Pyruvate oxidase (POX) was chosen for AHAS homology modelling because POX and AHAS share a number of biochemical characteristics. For example, both AHAS and POX share aspects of enzymatic reaction mechanisms, as well as cofactor and metal requirements. In both enzymes thiamine pyrophosphate (TPP), flavin adenine dinucleotide (FAD), and a divalent cation are required for enzymatic activity. FAD mediates a redox reaction during catalysis in POX but presumably has only a structural function in AHAS, which is possibly a vestigial remnant from the evolution of AHAS from POX. Both enzymes utilize pyruvate as a substrate and form hydroxyethyl thiamine pyrophosphate as a stable reaction intermediate (Schloss, J. V. et al. In Biosynthesis of branched chain amino acids, Barak, Z. J. M., Chipman, D. M., Schloss, J. V. (eds) VCH Publishers, Weinheim, Germany, 1990).
Additionally, AHAS activity is present in chimeric POX-AHAS proteins consisting of the N-terminal half of POX and the C-terminal half of AHAS, and there is a small degree of AHAS activity exhibited by POX itself. AHAS and POX also exhibit similar properties in solution (Risse, B. et al, Protein Sci. 1: 1699 and 1710, 1992; Singh, B. K., & Schmitt, G. K. (1989), FEBS Letters, 258: 113; Singh, B. K. et al. (1989) In: Prospects for Amino Acid Biosynthesis Inhibitors in Crop Protection and Pharmaceutical Chemistry, (Lopping, L. G., et al., eds., BCPC Monograph p. 87). With increasing protein concentration, both POX and AHAS undergo stepwise transitions from monomers to dimers and tetramers. Increases in FAD concentration also induce higher orders of subunit assembly. The tetrameric form of both proteins is most stable to heat and chemical denaturation.
Furthermore, the crystal structure of POX from Lactobacillus planarum had been solved by Muller et al., Science 259:965, 1993. The present inventors found that based in part upon the degree of physical, biochemical, and genetic homology between AHAS and POX, the X-ray crystal structure of POX could be used as a structural starting point for homology modelling of the AHAS structure.
AHAS and L. plantarum POX sequences were not similar enough for a completely computerized alignment, however. Overall, only about 20% of the amino acids are identical, while about 50% of the residues are of similar class (i.e. acidic, basic, aromatic, and the like). However, if the sequences are compared with respect to hydrophilic and hydrophobic residue classifications, over 500 of the 600 amino acids match. Secondary structure predictions for AHAS (Holley et al., Proc.Natl.Acad. Sci. USA 86:152, 1989) revealed a strong similarity to the actual secondary structure of POX. For nearly 70% of the residues, the predicted AHAS secondary structure matches that of POX.
POX monomers consist of three domains, all having a central, parallel .beta.-sheet with crossovers consisting of .alpha.-helices and long loops. (Needleman et al, J. Mol. Biol. 48:443, 1970). The topology of the sheets differs between the domains, i.e. in the first and third domains, the strands are assembled to the .beta.-sheet in the sequence 2-1-3-4-6-5, while in the .beta.-sheet of the second domain, the sequence reads 3-2-1-4-5-6.
Computer generated alignments were based on secondary structure prediction and sequence homology. The conventional pair-wise sequence alignment method described by Needleman and Wunch, J. Mol. Biol, 48: 443, 1970, was used. Two sequences were aligned to maximize the alignment score. The alignment score (homology score) is the sum of the scores for all pairs of aligned residues, plus an optional penalty for the introduction of gaps into the alignment. The score for the alignment of a pair of residues is a tabulated integer value. The homology scoring system is based on observing the frequency of divergence between a given pair of residues. (M O Dayhoff, R M Schwartz & B C Orcutt "Atlas of Protein Sequence and Structure" vol. 5 suppl. 3 pp. 345-362, 1978).
The alignments were further refined by repositioning gaps so as to conserve continuous regular secondary structures. Amino acid substitutions generated by evaluation of likely alignment schemes were compared by means of interactive molecular graphics. Alignments with the most conservative substitutions with respect to the particular functionality of the amino acids within a given site were chosen. The final alignment of both POX and AHAS is displayed in FIG. 2. Conserved clusters of residues were identified, in particular for the TPP binding site and for parts of the FAD binding site. The alignment revealed a high similarity between AHAS and POX for the first domain, for most parts of the second domain, and for about half of the third domain. Most of the regions that aligned poorly and may fold differently in POX and in AHAS were expected to be at the surface of the protein and were not involved in cofactor or inhibitor binding. The prediction of mutation sites is not substantially affected by small shifts in the alignment.
Most TPP binding residues are highly conserved between POX and AHAS (e.g. P48-G49-G50). In some cases, residues that were close to TPP differ between POX and AHAS but remain within a region that is highly conserved (for example, residues 90-110). On the other hand, the FAD binding site appeared to be less conserved. Although some FAD binding resides were strongly conserved (for example, D325-I326-D327-P328), others clearly differed between AHAS and POX (for example, residues in the loop from positions 278 to 285 are not homologous. A detailed analysis revealed that, at least for some of the less-conserved contact sites, the interactions were mediated by the polypeptide backbone rather than by the side chains. Hence, conservation was only required for the polypeptide fold and was not required for the amino acid sequence (for example, the backbone of residues 258-263 binds the ribitol chain of FAD). One half of the adenine and the isoalloxazine binding sites clearly differ.
After aligning the primary structure, a homology model was built by transposition of AHAS amino acid sequences to the POX template structure. Missing coordinates were built stepwise using templates of amino acid residues to complete undefined side chains. Data bank searches and energy minimization of small parts of the molecule were used to complete the conformations of undefined loop regions. The cofactors TPP and FAD were modeled into their binding pockets. This model was then subjected to a complete, 5000 cycle energy minimization. All computer modelling was performed in an IRIS Indigo Elan R4000 Workstation from Silicon Graphics Co. Interactive molecular modelling and energy-minimization were performed using Quanta/CHARMm 4.0 from Molecular Simulations Inc. During this step, the conformation was stable, indicating that no strongly disfavored interactions, such as, for example, close van der Waals contacts, had occurred. The results are shown schematically in FIG. 3.
Characteristics of Predicted AHAS Structure
Inspection of the modelled AHAS structure described above revealed that most of the protein folds with a backbone that is energetically reasonable, with most hydrophilic side chains accessible to the solvent. The surface of the .beta.-sheets are smooth and accommodate the cross-over regions that are attached to them.
A model for dimeric AHAS was generated by duplicating the coordinates of the energy minimized monomeric AHAS and superimposing the two copies on two POX subunits using pairs of C.alpha. coordinates as defined in the alignment scheme. The polypeptide chain of AHAS folds into three similarly folded domains composed of a six-stranded parallel .beta.-sheet core surrounded by long "loops" and .alpha.-helices. Two subunits are assembled such that the first domain of one subunit is in close proximity to the cofactor-binding domains 2 and 3 of the other subunit. A solvent-filled space remains between the subunits at this site. This pocket, which is defined by the confluence of the three domains, is the proposed entry site for the substrate. It is also proposed to be the binding site for herbicides.
The inner surface of the binding pocket is outlined by the cofactors. The thiazol of TPP is positioned at the bottom of the pocket. Domain 3 contributes to the inner surface of the pocket with a short .alpha.-helix that points its axis towards the pyrophosphate of TPP, compensating the phosphate charges with its dipolar moment. This critical helix, which starts with G498, a "turn" residue in close contact with TPP, and which ends at F507, contains three known mutation sites for sulfonylurea resistance: V500, W503, and F507 (See, U.S. Pat. Nos. 5,013,659; 5,141,870; and 5,378,824). In domain 1, the loop defined as P48-S52 (between .beta.-strand 2 and .alpha.-helix 2) faces W503, a mutation in which confers resistance to imidazolinones. Residues Y47 to G50 are also in contact with TPP. This loop is adjacent to P184-Q189, another turn, which connects the last strand of the .beta.-sheet of domain 1 with a .beta.-strand that connects with domain 2. Within the pocket, near its entrance, is a long region of domain 1 that interacts with a complementary stretch of domain 2. Residues 125-129 and 133-137 of domain 1 and residues 304-313 of domain 2 are at the surface of the pocket. A turn consisting of T96-G100 is between loop 125-129 and TPP. A further stretch of domain 3 and two regions of domain 2 that line the binding pocket are at the opposite comer of the pocket. Residues 572, 575, 582, and 583 of domain 3 define the pocket surface on one side. The remaining part of the interior of the pocket's surface is defined by FAD and by a loop, L278-G282, that contacts the isoalloxazine ring of FAD.
The structural models of the AHAS protein can also be used for the rational design of herbicides or AHAS inhibitors.
2. Modelling of Herbicides Into Binding Sites
Imazethapyr, the active imidazolinone in PURSUIT.RTM., was positioned into its proposed binding site using interactive molecular graphics (FIG. 4) and the software described above (FIG. 4). K185 was chosen as an "anchor" to interact with the charge of the carboxyl group. The imidazolinone's NH--CO unit was placed to form hydrogen bonds to G50 and A51. This positioned the methyl substitute of imazethapyr close to V500 on the backbone of the small .alpha.-helix. The isopropyl group is possibly bound by hydrophobic residues of the amino acids in the region of residues 125-135 that contribute to the inner surface of the pocket. The pyridine ring is most probably "sandwiched" between A134 or F135, F507 and W503. W503 also interacts with the imidazolinone ring system.
In a similar fashion, the sulfonylurea herbicides were modelled into a site that partially overlapped the described imidazolinone binding site. Overlap of sulfonylurea and imidazolinone binding sites was consistent with competition binding experiments and with established mutant data, which show that the same mutation in maize, W503L, can confer resistance to both herbicides. In these models, most of the known mutation sites that confer sulfonylurea herbicide resistance, i.e. G50, A51, K185, V500, W503, F507, are in close contact to the bound herbicides. P126 and A51 are required for keeping the K185 side chain in place by generating a hydrophobic pore. S582, a site for specific imidazolinone resistance, is distant from the binding region and is located in the region where the homology is so poor that a change in the fold is expected. The FAD binding site apparently has low homology between AHAS and POX in this region; S582 is a residue that confers resistance in maize, and that S582 and its adjacent residues are in close contact to the active site pocket. It is proposed that FAD and the loop region encompassing residues 278 to 285 move slightly away from the third domain, (downward in FIG. 4) and that a loop that contains S582 folds into the space between the helix at positions 499 to 507 and the loop at positions 278 to 285. D305, another known resistance site, is close to FAD and modulates the interaction between domains 1 and 2. M280 may either be involved in positioning of the helix at positions 498 to 507 or directly in inhibitor binding. M280 and D305 could also be directly involved in inhibitor binding if domains 1 and 2 move slightly closer to each other.
3. Selection of Mutations
Specific amino acid residues are pinpointed as sites for the introduction of mutations into the primary sequence of AHAS. These amino acids are selected based upon their position in that if that amino acid residue position is modified, there will be a resultant alteration (i.e. decline) in the affinity of an herbicide for the binding pocket. It is not necessary that the mutation position reside in the binding pocket as amino acid residues outside the pocket itself can alter the pocket charge or configuration. The selection of target sites for mutation is achieved using molecular models as described above. For example according to the model above, arginine at position 128 (designated R128 in FIG. 1 using the single-letter code for amino acids) is located near the entrance to the substrate- and herbicide-binding pocket and has a large degree of conformational freedom that may allow it to participate in transport of charged herbicides into the binding pocket. Therefore, this residue is substituted by alanine to remove both its charge and its long hydrophobic side chain. (The resulting mutation is designated R128A).
The mutations may comprise simple substitutions, which replace the wild-type sequence with any other amino acid. Alternatively, the mutations may comprise deletions or additions of one or more amino acids, preferably up to 5, at a given site. The added sequence may comprise an amino acid sequence known to exist in another protein, or may comprise a completely synthetic sequence. Furthermore, more than one mutation and/or more than one type of mutation may be introduced into a single polypeptide.
4. Site-Directed Mutagenesis
The DNA encoding AHAS can be manipulated so as to introduce the desired mutations. Mutagenesis is carried out using methods that are standard in the art, as described in, for example, Higuchi, R., Recombinant PCR, In M. A. Innis, et al., eds, PCR Protocols: A Guide to Methods and Applications, Academic Press, pp. 177-183, 1990.
5. Expression and Purification of Variants
The mutated or variant AHAS sequence is cloned into a DNA expression vector (see, e.g., Example 3) and is expressed in a suitable cell such as, for example, E. coli. Preferably, the DNA encoding AHAS is linked to a transcription regulatory element, and the variant AHAS is expressed as part of a fusion protein, for example, glutathione-S-transferase, to facilitate purification (see Example 3 below). The variant AHAS is then purified using affinity chromatography or any other suitable method known in the art. "Purification" of an AHAS polypeptide refers to the isolation of the AHAS polypeptide in a form that allows its enzymatic activity to be measured without interference by other components of the cell in which the polypeptide is expressed.
6. Assaying of Enzymatic Properties
The purified variant AHAS may be assayed for one or more of the following three properties:
(a) specific or catalytic activity for conversion of pyruvate to acetolactate (expressed as units/mg pure AHAS, wherein a unit of activity is defined as 1 .mu.mole acetolactate produced/hour), or for condensation of pyruvate and 2-ketobutyrate to form acetohydroxybutyrate (expressed as units/mg pure AHAS, wherein a unit of activity is defined as 1 .mu.mole acetohydroxybutyrate produced/hr.;
(b) level of inhibition by herbicide, such as, for example, imidazolinone (expressed as IC.sub.50, the concentration at which 50% of the activity of the enzyme is inhibited); and
(c) selectivity of resistance to the selected herbicide vs. other herbicides. The selectivity index is defined as the fold resistance of the mutant to imidazolinones relative to the wild-type enzyme, divided by the fold resistance of the same mutant to other herbicides also relative to the wild-type). Fold resistance to an herbicide relative to the wild-type enzyme is expressed as the IC.sub.50 of variant, divided by the IC.sub.50 of the wild type. The selectivity index (S.I.) is thus represented by the following equation: ##EQU1##
Suitable assay systems for making these determinations include, but are not limited to, those described in detail in Example 4 below.
7.a. Evaluation of Suitable Variants
The enzymatic properties of variant AHAS polypeptides are compared to the wild-type AHAS. Preferably, a given mutation results in an AHAS variant polypeptide that retains in vitro enzymatic activity towards pyruvate or pyruvate and 2-ketobutyrate, i.e., the conversion of pyruvate to acetolactate or in the condensation of pyruvate and 2-ketobutyrate to form acetohydroxybutyrate (and thus is expected to be biologically active in vivo), while exhibiting catalytic activity that is relatively more resistant to the selected herbicide(s) than is wild-type AHAS. Preferably, the variant AHAS exhibits:
(i) in the absence of the at least one herbicide,
(a) catalytic activity alone sufficient to maintain the viability of a cell in which it is expressed; or
(b) catalytic activity in combination with any herbicide resistant AHAS variant protein also expressed in the cell, which may be the same as or different than the first AHAS variant protein, sufficient to maintain the viability of a cell in which it is expressed;
wherein the cell requires AHAS activity for viability; and
(ii) catalytic activity that is more resistant to the at least one herbicide than is wild type AHAS;
and that is relatively more resistant to the herbicide(s) than is wild-type AHAS.
Therefore, any one specific AHAS variant protein need not have the total catalytic activity necessary to maintain the viability of the cell, but must have some catalytic activity in an amount, alone or in combination with the catalytic activity of additional copies of the same AHAS variant and/or the catalytic activity of other AHAS variant protein(s), sufficient to maintain the viability of a cell that requires AHAS activity for viability. For example, catalytic activity may be increased to minimum acceptable levels by introducing multiple copies of a variant encoding gene into the cell or by introducing the gene which further includes a relatively strong promoter to enhance the production of the variant.
More resistant means that the catalytic activity of the variant is diminished by the herbicide(s), if at all, to a lesser degree than wild-type AHAS catalytic activity is diminished by the herbicide(s). Preferred more resistant variant AHAS retains sufficient catalytic to maintain the viability of a cell, plant, or organism wherein at the same concentration of the same herbicide(s), wild-type AHAS would not retain sufficient catalytic activity to maintain the viability of the cell, plant, or organism.
Preferably the catalytic activity in the absence of herbicide(s) is at least about 5% and, most preferably, is more than about 20% of the catalytic activity of the wild-type AHAS in the absence of herbicide(s). Most preferred AHAS variants are more resistant to imidazolinone herbicides than to other herbicides such as sulfonylurea-based herbicides, though in some applications selectivity is neither needed nor preferred.
In the case of imidazolinone-resistant variant AHAS, it is preferred that the AHAS variant protein has
(i) catalytic activity in the absence of said herbicide of more than about 20% of the catalytic activity of said wild-type AHAS;
(ii) catalytic activity that is relatively more resistant to presence of imidazolinone herbicides compared to wild type AHAS; and
(iii) catalytic activity that is relatively more sensitive to the presence of sulfonylurea herbicides compared to imidazolinone herbicides. Most preferred herbicide-resistant AHAS variants exhibit a minimum specific activity of about 20 units/mg, minimal or no inhibition by imidazolinone, and a selectivity index ranging from about 1.3 to about 3000 relative to other herbicides.
Without wishing to be bound by theory, it is believed that systematic and iterative application of this method to wild type or other target AHAS protein will result in the production of AHAS variants having the desired properties of high enzymatic activity as explained above and resistance to one or more classes of herbicides. For example, mutation of a wild-type AHAS sequence at a particular position to a given amino acid may result in a mutant that exhibits a high degree of herbicide resistance but a significant loss of enzymatic activity towards pyruvate or pyruvate and 2-ketobutyrate. In a second application of the above method, the starting or target AHAS polypeptide would then be this variant (in place of the wild-type AHAS). Rational design then involves substituting other amino acids at the originally mutated position and/or adding or deleting amino acids at selected points or ranges in the expectation of retaining herbicide resistance but also maintaining a higher level of enzymatic activity.
The structure-based rational design of herbicide resistant AHAS proteins offers many advantages over conventional approaches that rely on random mutagenesis and selection. For example, when substitution of a particular amino acid with another requires substitution of more than one nucleotide within the codon, the likelihood of this occurring randomly is so low as to be impractical. By contrast, even double or triple changes in nucleotide sequence within a codon can be easily implemented when suggested by a rational design approach. For example, one rationally designed mutation to confer selective imidazolinone resistance requires a change from arginine to glutamate. Arginine is encoded by CGT, CGC, CGA, CGG, AGA, AGG, while glutamate is encoded by GAA and GAG. Since none of the arginine codons begins with GA, this mutation would require a double substitution of adjacent nucleotides which would occur so rarely using random mutagenesis as to be unpredictable and unrepeatable with any certainty of success. Although mutation frequency can be increased during random mutagenesis, alterations in nucleotide sequence would have an equal probability of occurring throughout the AHAS gene, in the absence of prior site-direction of the mutations. This increases the chance of obtaining an irrelevant mutation that interferes with enzymatic activity. Similarly, it would be rare, using random mutagenesis, to find a multiple amino acid substitution, deletion, or substitution/deletion mutation that confers herbicide resistance while maintaining catalytic activity. Deletion mutations that confer herbicide resistance would also be unlikely using a random mutagenesis approach. Deletions would need to be limited to small regions and would have to occur in triplets so as to retain the AHAS reading frame in order to retain enzymatic activity.
However, with a rational structure-based approach, double amino acid substitution and/or deletion mutations are relatively easily achieved and precisely targeted. Furthermore, different mutagens used in random mutagenesis create specific types of mutations. For example, sodium azide creates point substitution mutations in plants, while radiation tends to create deletions. Accordingly, two mutagenesis protocols would have to be employed to obtain a multiple combination substitution/deletion.
Finally, the present structure-based method for rational design of herbicide-resistant AHAS variants allows for iterative improvement of herbicide resistance mutations, a step that is not facilitated by random mutagenesis. Identification of a mutation site for herbicide resistance by random mutagenesis may offer little, if any, predictive value for guiding further improvements in the characteristics of the mutant. The present structure-based approach, on the other hand, allows improvements to be implemented based on the position, environment, and function of the amino acid position in the structural model.
The iterative improvement method also allows the independent manipulation of three important properties of AHAS: level of resistance, selectivity of resistance, and catalytic efficiency. For example, compensatory mutations can be designed in a predictive manner. If a particular mutation has a deleterious effect on the activity of an enzyme, a second compensatory mutation may be used to restore activity. For example, a change in the net charge within a domain when a charged residue is introduced or lost due to a mutation can be compensated by introducing a second mutation. Prediction of the position and type of residue(s) to introduce, delete, or substitute at the second site in order to restore enzymatic activity requires a knowledge of structure-function relationships derived from a model such as that described herein.
7.b. Design of Non-Peptide Herbicides or AHAS Inhibitors
A chemical entity that alters and may fit into the activity site of the target protein may be designed by methods known in the art, such as, for example, computer design programs that assist in the design of compounds that specifically interact with a receptor site.
An example of such a program is LUDI (Biosym Technologies--San Diego, Calif.) (see also, Lam, et al., Science 263:380, 1994; Thompson, et al., J. Med. Chem., 37:3100, 1994).
The binding pocket and particularly the amino acid residues that have been identified as being involved as inhibitor binding can be used as anchor points for inhibitor design.
The design of site-specific herbicides is advantageous in the control of weed species that may spontaneously develop herbicide resistance in the field, particularly due to mutations in the AHAS gene.
Herbicide-Resistant AHAS Variants: DNA, Vectors, and Polypeptides
The present invention also encompasses isolated DNA molecules encoding variant herbicide-resistant AHAS polypeptides. Genes encoding AHAS polypeptides according to the present invention may be derived from any species and preferably a plant species, and mutations conferring herbicide resistance may be introduced at equivalent positions within any of these AHAS genes. The equivalence of a given codon position in different AHAS genes is a function of both the conservation of primary amino acid sequence and its protein and the retention of similar three-dimensional structure. For example, FIG. 5 illustrates the high degree of sequence homology between AHAS polypeptides derived from different plant species. These AHAS polypeptides exhibit at least about 60 to about 70% overall homology. Without wishing to be bound by theory, it is believed that in regions of the polypeptide having a highly conserved sequence, the polypeptide chain conformation will also be preserved. Thus, it is possible to use an AHAS-encoding sequence from one species for molecular modelling, to introduce mutations predictively into an AHAS gene from a second species for initial testing and iterative improvement, and finally, to introduce the optimized mutations into AHAS derived from yet a third plant species for expression in a transgenic plant.
In one series of embodiment, these AHAS DNAs encode variants of an AHAS polypeptide and preferably of the maize AHAS polypeptide of FIG. 1 in which the polypeptide is modified by substitution at or deletion preceding or following one or more of FIG. 1 amino acid residues P48, G49, S52, M53, E54, A84, A95, T96, S97, G98, P99, G100, A101, V125, R127, R128, M129, I130, G131, T132, D133, F135, Q136, D186, I187, T259, T260, L261, M262, G263, R276, M277, L278, G279, H281, G282, T283, V284, G300, V301, R302, F303, D304, R306, V307, T308, G309, K310, I311, E312, A313, F314, A315, S316, R317, A318, K319, I320, E329, I330, K332, N333, K334, Q335, T404, G413, V414, G415, Q416, H417, Q418, M419, W420, A421, A422, L434, S435, S436, A437, G438, L439, G440, A441, M442, G443, D467, G468, S469, L471, N473, L477, M479, Q495, H496, L497, G498, M499, V501, Q502, Q504, D505, R506, Y508, K509, A510, N511, R512, A513, H514, T515, S524, H572, Q573, E574, H575, V576, L577, P578, M579, I580, P581, G583, G584, functional equivalents of any of the foregoing; insertions or deletions between FIG. 1 Q124 and H150 or functional equivalents thereof; insertions or deletions between FIG. 1 G300 and D324 or functional equivalents thereof; and any combination of any of the foregoing thereof.
The mutations, whether introduced into the polypeptide of FIG. 1 or at equivalent positions in another plant AHAS gene, may comprise alterations in DNA sequence that result in a simple substitution of any one or more other amino acids or deletions of up to 5 amino acid residues proceeding or up to 5 amino acids residues following any of the residence listed above. Suitable amino acid substituents include, but are not limited to, naturally occurring amino acids.
Alternatively, the mutations may comprise alterations in DNA sequence such that one or more amino acids are added or deleted in frame at the above positions. Preferably, additions comprise about 3 to about 30 nucleotides, and deletions comprise about 3 to about 30 nucleotides. Furthermore, a single mutant polypeptide may contain more than one similar or different mutation.
The present invention encompasses DNA and corresponding RNA sequences, as well as sense and antisense sequences. Nucleic acid sequences encoding AHAS polypeptides may be flanked by natural AHAS regulatory sequences, or may be associated with heterologous sequences, including promoters, enhancers, response elements, signal sequences, polyadenylation sequences, introns, 5'- and 3'- noncoding regions, and the like. Furthermore, the nucleic acids can be modified to alter stability, solubility, binding affinity and specificity. For example, variant AHAS-encoding sequences can be selectively methylated. The nucleic acid sequences of the present invention may also be modified with a label capable of providing a detectable signal, either directly or indirectly. Exemplary labels include radioisotopes, fluorescent molecules, biotin, and the like.
The invention also provides vectors comprising nucleic acids encoding AHAS variants. A large number of vectors, including plasmid and fungal vectors, have been described for expression in a variety of eukaryotic and prokaryotic hosts. Advantageously, vectors may also include a promotor operably linked to the AHAS encoding portion. The encoded AHAS may be expressed by using any suitable vectors and host cells, using methods disclosed or cited herein or otherwise known to those skilled in the relevant art. Examples of suitable vectors include without limitation pBIN-based vectors, pBluescript vectors, and pGEM vectors.
The present invention also encompasses both variant herbicide-resistant AHAS polypeptides or peptide fragments thereof. As explained above, the variant AHAS polypeptides may be derived from the maize polypeptide shown in FIG. 1 or from any plant or microbial AHAS polypeptide, preferably plant AHAS polypeptide. The polypeptides may be further modified by, for example, phosphorylation, sulfation, acylation, glycosylation, or other protein modifications. The polypeptides may be isolated from plants, or from heterologous organisms or cells (including, but not limited to, bacteria, yeast, insect, plant, and mammalian cells) into which the gene encoding a variant AHAS polypeptide has been introduced and expressed. Furthermore, AHAS polypeptides may be modified with a label capable of providing a detectable signal, either directly or indirectly, including radioisotopes, fluorescent compounds, and the like.
Chemical-Resistant Plants and Plants Containing Variant AHAS Genes
The present invention encompasses transgenic cells, including, but not limited to seeds, organisms, and plants into which genes encoding herbicide-resistant AHAS variants have been introduced. Non-limiting examples of suitable recipient plants are listed in Table 1 below:
TABLE 1______________________________________RECIPIENT PLANTSCOMMON NAME FAMILY LATIN NAME______________________________________Maize Gramineae Zea maysMaize, Dent Gramineae Zea mays dentiformisMaize, Flint Gramineae Zea mays vulgarisMaize, Pop Gramineae Zea mays microspermaMaize, Soft Gramineae Zea mays amylaceaMaize, Sweet Gramineae Zea mays amyleasaccharataMaize, Sweet Gramineae Zea mays saccharateMaize, Waxy Gramineae Zea mays ceratinaWheat, Dinkel Pooideae Triticum speltaWheat, Durum Pooideae Triticum durumWheat, English Pooideae Triticum turgidumWheat, Large Spelt Pooideae Triticum speltaWheat, Polish Pooideae Triticum poloniumWheat, Poulard Pooideae Triticum turgidumWheat, Single- Pooideae Triticum monococcumgrainedWheat, Small Spelt Pooideae Triticum monococcumWheat, Soft Pooideae Triticum aestivumRice Gramineae Oryza sativaRice, American Gramineae Zizania aquaticaWildRice, Australian Gramineae Oryza australiensisRice, Indian Gramineae Zizania aquaticaRice, Red Gramineae Oryza glaberrimaRice, Tuscarora Gramineae Zizania aquaticaRice, West African Gramineae Oryza glaberrimaBarley Pooideae Hordeum vulgareBarley, Abyssinian Pooideae Hordeum irregulareIntermediate, alsoIrregularBarley, Ancestral Pooideae Hordeum spontaneumTworowBarley. Beardless Pooideae Hordeum trifurcatumBarley, Egyptian Pooideae Hordeum trifurcatumBarley, fourrowed Pooideae Hordeum vulgare polystichonBarley, sixrowed Pooideae Hordeum vulgare hexastichonBarley, Tworowed Pooideae Hordeum distichonCotton, Abroma Dicotyledoneae Abroma augustaCotton, American Malvaceae Gossypium hirsutumUplandCotton, Asiatic Malvaceae Gossypium arboreumTree, also IndianTreeCotton, Brazilian, Malvaceae Gossypium barbadensealso, Kidney, and, brasiliensePernambucoCotton, Levant Malvaceae Gossypium herbaceumCotton, Long Silk, Malvaceae Gossypium barbadensealso Long Staple,Sea IslandCotton, Mexican, Malvaceae Gossypium hirsutumalso Short StapleSoybean, Soya Leguminosae Glycine maxSugar beet Chenopodiaceae Beta vulgaris altissimaSugar cane Woody-plant Arenga pinnataTomato Solanaceae Lycopersicon esculentumTomato, Cherry Solanaceae Lycopersicon esculentum cerasiformeTomato, Common Solanaceae Lycopersicon esculentum communeTomato, Currant Solanaceae Lycopersicon pimpinellifoliumTomato, Husk Solanaceae Physalis ixocarpaTomato, Hyenas Solanaceae Solanum incanumTomato, Pear Solanaceae Lycopersicon esculentum pyriformeTomato, Tree Solanaceae Cyphomandra betaceaPotato Solanaceae Solanum tuberosumPotato, Spanish, Convolvulaceae Ipomoea batatasSweet potatoRye, Common Pooideae Secale cerealeRye, Mountain Pooideae Secale montanumPepper, Bell Solanaceae Capsicum annuum grossumPepper, Bird, also Solanaceae Capsicum annuum minimumCayenne, GuineaPepper, Bonnet Solanaceae Capsicum sinensePepper, Bullnose, Solanaceae Capsicum annuum grossumalso SweetPepper, Cherry Solanaceae Capsicum annuum cerasiformePepper, Cluster, also Solanaceae Capsicum annuum fasciculatumRed ClusterPepper, Cone Solanaceae Capsicum annuum conoidesPepper, Goat, also Solanaceae Capsicum frutescensSpurPepper, Long Solanaceae Capsicum frutescens longumPepper, Orana- Solanaceae Capsicum annuum abbreviatummental Red,also WrinkledPepper, Tabasco Solanaceae Capsicum annuum conoidesRedLettuce, Garden Compositae Lactuca sativaLettuce, Asparagus, Compositae Lactuca sativa asparaginaalso CeleryLettuce, Blue Compositae Lactuca perennisLettuce, Blue, also Compositae Lactuca pulchellaChicoryLettuce, Cabbage, Compositae Lactuca sativa capitataalso HeadLettuce, Cos, also Compositae Lactuca sativa longifoliaLongleaf, RomaineLettuce, Crinkle, Compositae Lactuca sativa crispaalso Curled,Cutting, LeafCelery Umbelliferae Apium graveolens dulceCelery, Blanching, Umbelliferae Apium graveolens dulcealso GardenCelery, Root, also Umbelliferae Apium graveolens rapaceumTurniprootedEggplant, Garden Solanaceae Solanum melongenaSorghum Sorghum All crop speciesAlfalfa Leguminosae Medicago sativumCarrot Umbelliferae Daucus carota sativaBean, Climbing Leguminosae Phaseolus vulgaris vulgarisBean, Sprouts Leguminosae Phaseolus aureusBean, Brazilian Leguminosae Canavalia ensiformisBroadBean, Broad Leguminosae Vicia fabaBean, Common, Leguminosae Phaseolus vulgarisalso French, White,KidneyBean, Egyptian Leguminosae Dolichos lablabBean, Long, also Leguminosae Vigna sesquipedalisYardlongBean, Winged Leguminosae Psophocarpus tetragonolobusOat, also Common, Avena SativaSide, TreeOat, Black, also Avena StrigosaBristle, LopsidedOat, Bristle AvenaPea, also Garden, Leguminosae Pisum, sativum sativumGreen, ShellingPea, Blackeyed Leguminosae Vigna sinensisPea, Edible Podded Leguminosae Pisum sativum axiphiumPea, Grey Leguminosae Pisum sativum speciosumPea, Winged Leguminosae Tetragonolobus purpureusPea, Wrinkled Leguminosae Pisum sativum medullareSunflower Compositae Helianthus annuusSquash, Autumn, Dicotyledoneae Cucurbita maximaWinterSquash, Bush, also Dicotyledoneae Cucurbita pepo melopepoSummerSquash, Turban Dicotyledoneae Cucurbita maxima turbaniformisCucumber Dicotyledoneae Cucumis sativusCucumber, African, Momordica charantiaalso BitterCucumber, Ecballium elateriumSquirting, also WildCucumber, Wild Cucumis anguriaPoplar, California Woody-Plant Populus trichocarpaPoplar, European Populus nigraBlackPoplar, Gray Populus canescensPoplar, Lombardy Populus italicaPoplar, Silverleaf, Populus albaalso WhitePoplar, Western Populus trichocarpaBalsamTobacco Solanaceae NicotianaArabidopsis Cruciferae Arabidopsis thalianaThalianaTurfgrass LoliumTurfgrass Agrostis Other families of turfgrassClover Leguminosae______________________________________
Expression of the variant AHAS polypeptides in transgenic plants confers a high level of resistance to herbicides including, but not limited to, imidazolinone herbicides such as, for example, imazethapyr (PURSUIT.RTM.), allowing the use of these herbicides during cultivation of the transgenic plants.
Methods for the introduction of foreign genes into plants are known in the art. Non-limiting examples of such methods include Agrobactenium infection, particle bombardment, polyethylene glycol (PEG) treatment of protoplasts, electroporation of protoplasts, microinjection, macroinjection, tiller injection, pollen tube pathway, dry seed imbibition, laser perforation, and electrophoresis. These methods are described in, for example, B. Jenes et al., and S. W. Ritchie et al. In Transgenic Plants, Vol. 1, Engineering and Utilization, ed. S.-D. Kung, R. Wu, Academic Press, Inc., Harcourt Brace Jovanovich 1993; and L. Mannonen et al., Critical Reviews in Biotechnology, 14:287-310, 1994.
Other Applications
The methods and compositions of the present invention can be used in the structure-based rational design of herbicide-resistant AHAS variants, which can be incorporated into plants to confer selective herbicide resistance on the plants. Intermediate variants of AHAS (for example, variants that exhibit sub-optimal specific activity but high resistance and selectivity, or the converse) are useful as templates for the design of second-generation AHAS variants that retain adequate specific activity and high resistance and selectivity.
Herbicide resistant AHAS genes can be transformed into crop species in single or multiple copies to confer herbicide resistance. Genetic engineering of crop species with reduced sensitivity to herbicides can:
(1) Increase the spectrum and flexibility of application of specific effective and environmentally benign herbicides such as imidazolinone herbicides;
(2) Enhance the commercial value of these herbicides;
(3) Reduce weed pressure in crop fields by effective use of herbicides on herbicide resistant crop species and a corresponding increase in harvest yields;
(4) Increase sales of seed for herbicide-resistant plants;
(5) Increase resistance to crop damage from carry-over of herbicides applied in a previous planting;
(6) Decrease susceptibility to changes in herbicide characteristics due to adverse climate conditions; and
(7) Increase tolerance to unevenly or mis-applied herbicides.
For example, transgenic AHAS variant protein containing plants can be cultivated. The crop can be treated with a weed controlling effective amount of the herbicide to which the AHAS variant transgenic plant is resistant, resulting in weed control in the crop without detrimentally affecting the cultivated crop.
The DNA vectors described above that encode herbicide-resistant AHAS variants can be further utilized so that expression of the AHAS variant provides a selectable marker for transformation of cells by the vector. The intended recipient cells may be in culture or in situ, and the AHAS variant genes may be used alone or in combination with other selectable markers. The only requirement is that the recipient cell is sensitive to the cytotoxic effects of the cognate herbicide. This embodiment takes advantage of the relative low cost and lack of toxicity of, for example, imidazolinone-based herbicides, and may be applied in any system that requires DNA-mediated transformation.
Description of the Preferred Embodiments
The following examples are intended to illustrate the present invention without limitation.
EXAMPLE 1
Design of Herbicide-Resistant AHAS Variants
Residues located close to the proposed herbicide binding site of the model described in detail above and are expected to be directly involved in enzymatic activity were selected for mutagenesis in order to design an active AHAS polypeptide with decreased herbicide binding capacity. Each site at the surface of the pocket was considered in terms of potential interactions with other residues in the pocket, as well as with cofactors and herbicides. For example, addition of positively charged residue(s) is expected to interfere with the charge distribution within the binding site, resulting in a loss in affinity of binding of a negatively-charged herbicide.
Three residues were identified as most useful targets for mutagenesis:
(1) F135 was believed to interact with both the isoalloxazine ring of FAD and with the aromatic group of the herbicides. In accordance with the strategy of introducing more charged residues into the binding pocket, this residue was changed to arginine.
(2) M53 contacts helix 498-507, which contains known herbicide resistance mutation sites and is also implicated in TPP binding. Furthermore, substitution of glutamic acid at position 53 was believed to favor an interaction with K185, reducing the affinity of K185 for the carboxylate group of imazethapyr.
(3) R128 is located near the entrance to the pocket, where it was believed to be involved in the initial transport of charged herbicides into the binding pocket. This residue was changed to alanine to remove both its charge and its long hydrophobic side chain.
EXAMPLE 2
Site-Directed Mutagenesis of AHAS to Produce Herbicide-Resistant Variants
The Arabidopsis AHAS gene was inserted in-frame to the 3' end of the coding region of the glutathione S-transferase gene in the pGEX-2T vector (Pharmacia). Construction of the vector in this manner maintained the six amino acid thrombin recognition sequence at the junction of the expressed glutathione-S-transferase (GST)/AHAS fusion protein. Thrombin digestion of the expressed fusion protein results in an AHAS protein with an N-terminal starting at a position halfway into the transit peptide, with a residual N-terminal glycine derived from the thrombin recognition site. The final amino terminus of the cleaved AHAS protein consists of Gly-Ser-Ser-Ile-Ser. Site-directed mutations were introduced into the AHAS gene in this vector.
Site-directed mutations were constructed according to the PCR method of Higuchi (Recombinant PCR. In MA Innis, et al. PCR Protocols: A Guide to Methods and Applications, Academic Press, San Diego, pp. 177-183, 1990). Two PCR products, each of which overlap the mutation site, were amplified. The primers in the overlap region contained the mutation. The overlapping PCR amplified fragments were combined, denatured, and allowed to re-anneal together, producing two possible heteroduplex products with recessed 3'-ends. The recessed 3'-ends were extended by Taq DNA polymerase to produce a fragment that was the sum of the two overlapping PCR products containing the desired mutation. A subsequent re-amplification of this fragment with only the two "outside" primers resulted in the enrichment of the full-length product. The product containing the mutation was then re-introduced into the Arabidopsis AHAS gene in the pGEX-2T vector.
EXAMPLE 3
Expression and Purification of AHAS Variants
A. Methods
E. Coli (DH5.alpha.) cells transformed with the pGEX-2T vector containing either the maize wild type AHAS gene (vector designation pAC751), the Arabidopsis Ser653Asn mutant, or the Arabidopsis Ile401Phe mutant were grown overnight in LB broth containing 50 .mu.g/mL ampicillin. The overnight culture of E. coli was diluted 1:10 in 1 L LB, 50 .mu.g/mL ampicillin, and 0.1% v/v antifoam A. The culture was incubated at 37.degree. C. with shaking until the OD.sub.600 reached approximately 0.8. Isopropylthiogalactose (IPTG) was added to a final concentration of 1 mM and the culture was incubated for 3 more hours.
Cells were harvested by centrifugation at 8,670.times.g for 10 minutes in a JA-10 rotor and resuspended in 1/100th of the original culture volume in MTPBS (16 mM Na.sub.2 HPO.sub.4, 4 mM NaH.sub.2 PO.sub.4, 150 mM NaCl, pH 7.3). Triton X-100 and lysozyme were added to a final concentration of 1% v/v and 100 .mu.g/mL, respectively. Cells were incubated at 30.degree. C. for 15 minutes cooled to 4.degree. C. on ice, and were lysed by sonication for 10 seconds at level 7 with a Branson Sonifier Cell Disrupter equipped with a microtip probe. The cell free extract was centrifuged at 35,000.times.g for 10 min. at 4.degree. C. The supernatant was decanted and the centrifugation step was repeated.
Purification of expressed fusion proteins was performed as modified from Smith and Johnson (Gene 67:31-40, 1988). The supernatant was warmed to room temperature and was passed through a 2 mL column of glutathione-agarose beads (sulfur linkage, Sigma) equilibrated in MTPBS. The column was subsequently washed with MTPBS at room temperature until the A.sub.280 of eluant matched that of MTPBS. The fusion protein was then eluted using a solution containing 5 mM reduced glutathione in 50 mM Tris HCL, pH 8.0. The eluted fusion protein was treated with approximately 30 NIH units of thrombin and dialyzed against 50 mM citrate pH 6.5 and 150 mM NaCl.
The fusion protein was digested overnight at room temperature. Digested samples were dialyzed against MTPBS and passed twice through a glutathione-agarose column equilibrated in MTPBS to remove the released glutathione transferase protein. The protein fraction that did not bind to the column was collected and was concentrated by ultrafiltration on a YM10 filter (Amicon). The concentrated sample was loaded onto a 1.5.times.95 cm Sepharcryl S-100 gel filtration column equilibrated in gel filtration buffer (50 mM HEPES, 150 mM NaCl, pH 7.0). Two mL fractions were collected at a flow rate of 0.14 mL/min. Enzyme stability was tested by storage of the enzyme at 4.degree. C. in gel filtration buffer with the addition of 0.02% sodium azide and in the presence or absence of 2 mM thiamine pyrophosphate and 100 .mu.M flavin adenine dinucleotide (FAD).
B. Results
E. coli transformed with the pAC751 plasmid containing the wide-type AHAS gene fused downstream and in-frame with the GST gene expressed a 91 kD protein when induced with IPTG. The 91 kD protein exhibited the predicted molecular mass of a GST/AHAS fusion protein (the sum of (26 kD and 65 kD, respectively). When the cell free extract of DH5.alpha./pAC751 was passed through a glutathione-agarose affinity gel, washed, and eluted with free glutathione it yielded a preparation enriched in the 91 kD protein (FIG. 6, lane C). The six amino acid thrombin recognition site engineered in the junction of GST and AHAS was successfully cleaved by thrombin (FIG. 6, lane D). The cleaved fusion protein preparation consisted of the expected 26 kD GST protein and the 65 kD maize AHAS protein. Maize AHAS was purified to homogeneity by a second pass through the glutathione-agarose column to affinity subtract GST and subjected to a final Sephacryl S-100 gel filtration step to eliminated thrombin (FIG. 6, lane E). The 65 kD protein is recognized on western blots by a monoclonal antibody raised against a maize AHAS peptide.
Purified wild type maize AHAS was analyzed by electrospray mass spectrometry and was determined to have a molecular mass of 64,996 daltons (data not shown). The predicted mass, as calculated from the deduced amino acid sequence of the gene inserted into the pGEX-2T vector, is 65,058. The 0.096% discrepancy between the empirically determined and predicted mass was within tuning variability of the mass spectrometer. The close proximity of the two mass determinations suggests that there were no misincorporated nucleotides during construction of the expression vector, nor any post-translational modifications to the protein that would cause gross changes in molecular mass. Moreover, the lack of spurious peaks in the preparation of purified enzyme indicated that the sample was free of contamination.
EXAMPLE 4
Enzymatic Properties of AHAS Variants
The enzymatic properties of wild-type and variant AHAS produced in E. coli were measured by a modification of the method of Singh et al. (Anal. Biochem 171:173-179, 1988) as follows:
A reaction mixture containing 1.times. AHAS assay buffer (50 mM HEPES pH 7.0, 100 mM pyruvate, 10 mM MgCl.sub.2, 1 mM thiamine pyrophosphate (TPP), and 50 .mu.M flavin adenine dinucleotide (FAD)) was obtained either by dilution of enzyme in 2.times. assay buffer or by addition of concentrated enzyme to 1.times. AHAS assay buffer. All assays containing imazethapyr and associated controls contained a final concentration of 5% DMSO due to addition of imazethapyr to assay mixtures as a 50% DMSO solution. Assays were performed in a final volume of 250 .mu.L at 37.degree. C. in microtiter plates. After allowing the reaction to proceed for 60 minutes, acetolactate accumulation was measured colorimetrically as described by Singh et al., Anal. Biochem 171:173-179, 1988.
Maize AHAS expressed and purified from pAC751 as described in Example 3 above is active in the conversion of pyruvate to acetolactate. Full AHAS activity is dependent on the presence of the cofactors FAD and TPP in the assay medium. No activity was detected when only FAD was added to the assay medium. The activity of the purified enzyme with TPP only, or with no cofactors, was less than 1% of the activity detected in the presence of both TPP and FAD. Normally, AHAS present in crude plant extracts is very labile, particularly in the absence of substrate and cofactors. In contrast, the purified AHAS from the bacterial expression system showed no loss in catalytic activity when stored for one month at 4.degree. C. in 50 mM HEPES pH 7.0, 150 mM NaCl, 0.02% NaN.sub.3 in the presence or absence of FAD and TPP. Furthermore, no degradation products were visible from these stored preparations when resolved in SDS-PAGE gels.
The specific activities of wild-type AHAS and the M125E, R200A, and F207R variants are shown in Table 2 below. As determined from the alignment in FIG. 5, the M125E mutation in Arabidopsis AHAS is the equivalent of the maize M53E mutation, the R200A mutation in Arabidopsis is the equivalent of the maize R128A mutation, and the F207R mutation in Arabidopsis is the equivalent of the maize F135R mutation. The mutations designed in the maize AHAS structural model were used to identify the equivalent amino acid in the dicot Arabidopsis AHAS gene and were incorporated and tested in the Arabidopsis AHAS gene. This translation and incorporation of rationally designed herbicide mutations into the dicot Arabidopsis AHAS gene can facilitate evaluation of herbicide resistance in plants of a dicot species.
TABLE 2______________________________________SPECIFIC ACTIVITY % Catalytic Activity as Specific Activity Compared to Wild Type______________________________________Wild-Type 147 100Met125Glu 13.5 9.2Arg200Ala 127 86Phe207Arg 7.49 5.1______________________________________
The R200A mutation maintains a high level of catalytic activity (Table 2) while exhibiting a significant level of resistance to imazethapyr (FIG. 7). Notably, this variant retains complete sensitivity to sulfonylureas (FIG. 8). Thus, this variant fulfills the criteria of high specific activity and selective herbicide resistance. By contrast, the M125E substitution resulted in almost complete resistance to imazethapyr (FIG. 7) but also exhibited severely reduced catalytic activity (Table 2). Relative to imidazolinone resistance, this variant exhibits greater sensitivity to sulfonylurea (FIG. 8), suggesting that this residue is a good candidate for creating a mutation that confers selective resistance. Substitution of an amino acid other than glutamic acid may help to maintain catalytic activity. The F207R substitution yielded similar results to those observed with M125E variant, but lacked selectivity in resistance.
EXAMPLE 5
Iterative Improvement of AHAS Herbicide-Resistant Variant Using a Rational Design Approach
Changing residue 125 in AHAS from Met to Glu as described in Example 4 above conferred imidazolinone resistance but also reduced enzymatic activity to 9.2% of the wild type value. The model of the maize AHAS structure described above suggested that Met53 (equivalent to the Arabidopsis Met125 residue) interacts with a series of hydrophobic residues on the face of an .alpha.-helix that is derived from a separate subunit but are in close proximity to Met53. Thus, the hydrophobic interaction between Met53 and the residues on the helix may stabilize both subunit/subunit association and the conformation of the active site. It was believed that the substitution of the hydrophobic Met residue with a charged glutamate residue most probably destabilizes the inter-subunit hydrophobic interaction and results in a loss of catalytic activity.
Based on this structure/function analysis, the activity of the original Arabidopsis Met125Glu (equivalent to maize Met53Glu) mutant enzyme was then iteratively improved by substituting a more hydrophobic amino acid (Ile) at this position. The hydrophobic nature of the Ile side chain resulted in restoration of activity to wild type levels (specific activity of 151, equivalent to 103% of the wild-type activity), but the greater bulk of the Ile side chain was still able to maintain a significant level of imidazolinone resistance (FIG. 9).
EXAMPLE 6
Iterative Improvement of AHAS Herbicide-Resistant Variant Using a Rational Design Approach
Another example of iterative refinement using the methods of the present invention involves the Arg128Ala variant. The structural model of maize AHAS suggested that the Arg128 residue, which resides at the lip of the herbicide binding pocket, contributes to channeling charged substrates and herbicides into the herbicide binding pocket and into the active site. The Arg 128 residue is distant from the TPP moiety, which binds the initial pyruvate molecule in the reaction mechanism of AHAS, explaining why the substitution of Arabidopsis AHAS Arg200, the equivalent to maize Arg128 to alanine, had little effect on the catalytic activity of the enzyme. The structural model further indicated that a more radical change could be made at this position to raise the level of resistance while maintaining high levels of catalytic activity. On this basis, an iterative improvement of the mutation was made to substitute the positively charge arginine residue with a negatively charged glutamate residue. The enzyme thus mutated had improved levels of resistance to PURSUIT.RTM. while maintaining high levels of activity (specific activity of 168, equivalent to 114% of the wild-type activity) (FIG. 10).
EXAMPLE 7
Interchangeability of AHAS Derived From Different Species in Structure-Based Rational Design of Herbicide-Resistant AHAS Variants
A structural model of the three-dimensional structure of AHAS is built with a monocot AHAS sequence such as that derived from maize, as described above. To introduce mutations into AHAS derived from a dicot species such as Arabidopsis, the sequences of AHAS derived from the monocot and dicot species are aligned using the GAP and PILEUP programs (Genetics Computer Group, 575 Sequence Drive, Modeom, W153711). Equivalent positions are determined from the computer-generated alignment. The mutations are then introduced into the dicot AHAS gene as described above. Following expression of the mutant AHAS protein in E.Coli and assessment of its biochemical properties (i.e., specific activity and resistance to herbicides), the mutant gene is introduced into a dicot plant by plant transformation methods as described above.
All patents, applications, articles, publications, and test methods mentioned above are hereby incorporated by reference.
Many variations of the present invention will suggest themselves to those skilled in the art in light of the above detailed description. Such obvious variations are within the full intended scope of the appended claims.
__________________________________________________________________________# SEQUENCE LISTING- (1) GENERAL INFORMATION:- (iii) NUMBER OF SEQUENCES: 10- (2) INFORMATION FOR SEQ ID NO:1:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 599 amino (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (iii) HYPOTHETICAL: NO- (vi) ORIGINAL SOURCE: (A) ORGANISM: Zea mays- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:- Gly Ser Ala Ala Ser Pro Ala Met - # Pro Met Ala Pro Pro Ala ThrPro# 15- Leu Arg Pro Trp Gly Pro Thr Asp - # Pro Arg Lys Gly Ala Asp IleLeu# 30- Val Glu Ser Leu Glu Arg Cys Gly - # Val Arg Asp Val Phe Ala TyrPro# 45- Gly Gly Ala Ser Met Glu Ile His - # Gln Ala Leu Thr Arg Ser ProVal# 60- Ile Ala Asn His Leu Phe Arg His - # Glu Gln Gly Glu Ala Phe AlaAla# 80- Ser Gly Tyr Ala Arg Ser Ser Gly - # Arg Val Gly Val Cys Ile AlaThr# 95- Ser Gly Pro Gly Ala Thr Asn Leu - # Val Ser Ala Leu Ala Asp AlaLeu# 110- Leu Asp Ser Val Pro Met Val Ala - # Ile Thr Gly Gln Val Pro ArgArg# 125- Met Ile Gly Thr Asp Ala Phe Gln - # Glu Thr Pro Ile Val Glu ValThr# 140- Arg Ser Ile Thr Lys His Asn Tyr - # Leu Val Leu Asp Val Asp AspIle# 160- Pro Arg Val Val Gln Glu Ala Phe - # Phe Leu Ala Ser Ser Gly ArgPro# 175- Gly Pro Val Leu Val Asp Ile Pro - # Lys Asp Ile Gln Gln Gln MetAla# 190- Val Pro Val Trp Asp Lys Pro Met - # Ser Leu Pro Gly Tyr Ile AlaArg# 205- Leu Pro Lys Pro Pro Ala Thr Glu - # Leu Leu Glu Gln Val Leu ArgLeu# 220- Val Gly Glu Ser Arg Arg Pro Val - # Leu Tyr Val Gly Gly Gly CysAla# 240- Arg Ser Gly Glu Glu Leu Arg Arg - # Phe Val Glu Leu Thr Gly IlePro# 255- Val Thr Thr Thr Leu Met Gly Leu - # Gly Asn Phe Pro Ser Asp AspPro# 270- Leu Ser Leu Arg Met Leu Gly Met - # His Gly Thr Val Tyr Ala AsnTyr# 285- Ala Val Asp Lys Ala Asp Leu Leu - # Leu Ala Leu Gly Val Arg PheAsp# 300- Asp Arg Val Thr Gly Lys Ile Glu - # Ala Phe Ala Ser Arg Ala LysIle# 320- Val His Val Asp Ile Asp Pro Ala - # Glu Ile Gly Lys Asn Lys GlnPro# 335- His Val Ser Ile Cys Ala Asp Val - # Lys Leu Ala Leu Gln Gly MetAsn# 350- Ala Leu Leu Glu Gly Ser Thr Ser - # Lys Lys Ser Phe Asp Phe GlySer# 365- Trp Asn Asp Glu Leu Asp Gln Gln - # Lys Arg Glu Phe Pro Leu GlyTyr# 380- Lys Tyr Ser Asn Glu Glu Ile Gln - # Pro Gln Tyr Ala Ile Gln ValLeu# 400- Asp Glu Leu Thr Lys Gly Glu Ala - # Ile Ile Gly Thr Gly Val GlyGln# 415- His Gln Met Trp Ala Ala Gln Tyr - # Tyr Thr Tyr Lys Arg Pro ArgGln# 430- Trp Leu Ser Ser Ala Gly Leu Gly - # Ala Met Gly Phe Gly Leu ProAla# 445- Ala Ala Gly Ala Ser Val Ala Asn - # Pro Gly Val Thr Val Val AspIle# 460- Asp Gly Asp Gly Ser Phe Leu Met - # Asn Val Gln Glu Leu Ala MetIle# 480- Arg Ile Glu Asn Leu Pro Val Lys - # Val Phe Val Leu Asn Asn GlnHis# 495- Leu Gly Met Val Val Gln Trp Glu - # Asp Arg Phe Tyr Lys Ala AsnArg# 510- Ala His Thr Tyr Leu Gly Asn Pro - # Glu Asn Glu Ser Glu Ile TyrPro# 525- Asp Phe Val Thr Ile Ala Lys Gly - # Phe Asn Ile Pro Ala Val ArgVal# 540- Thr Lys Lys Asn Glu Val Arg Ala - # Ala Ile Lys Lys Met Leu GluThr# 560- Pro Gly Pro Tyr Leu Leu Asp Ile - # Ile Val Pro His Gln Glu HisVal# 575- Leu Pro Met Ile Pro Ser Gly Gly - # Ala Phe Lys Asp Met Ile LeuAsp# 590- Gly Asp Gly Arg Thr Val Tyr 595- (2) INFORMATION FOR SEQ ID NO:2:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 585 amino (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (iii) HYPOTHETICAL: NO- (vi) ORIGINAL SOURCE: (A) ORGANISM: Lactobacillu - #s plantarum- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:- Thr Asn Ile Leu Ala Gly Ala Ala - # Val Ile Lys Val Leu Glu AlaTrp# 15- Gly Val Asp His Leu Tyr Gly Ile - # Pro Gly Gly Ser Ile Asn SerIle# 30- Met Asp Ala Leu Ser Ala Glu Arg - # Asp Arg Ile His Tyr Ile GlnVal# 45- Arg His Glu Glu Val Gly Ala Met - # Ala Ala Ala Ala Asp Ala LysLeu# 60- Thr Gly Lys Ile Gly Val Cys Phe - # Gly Ser Ala Gly Pro Gly GlyThr# 80- His Leu Met Asn Gly Leu Tyr Asp - # Ala Arg Glu Asp His Val ProVal# 95- Leu Ala Leu Ile Gly Gln Phe Gly - # Thr Thr Gly Met Asn Met AspThr# 110- Phe Gln Glu Met Asn Glu Asn Pro - # Ile Tyr Ala Asp Val Ala AspTyr# 125- Asn Val Thr Ala Val Asn Ala Ala - # Thr Leu Pro His Val Ile AspGlu# 140- Ala Ile Arg Arg Ala Tyr Ala His - # Gln Gly Val Ala Val Val GlnIle# 160- Pro Val Asp Leu Pro Trp Gln Gln - # Ile Ser Ala Glu Asp Trp TyrAla# 175- Ser Ala Asn Asn Tyr Gln Thr Pro - # Leu Leu Pro Glu Pro Asp ValGln# 190- Ala Val Thr Arg Leu Thr Gln Thr - # Leu Leu Ala Ala Glu Arg ProLeu# 205- Ile Tyr Tyr Gly Ile Gly Ala Arg - # Lys Ala Gly Lys Glu Leu GluGln# 220- Leu Ser Lys Thr Leu Lys Ile Pro - # Leu Met Ser Thr Tyr Pro AlaLys# 240- Gly Ile Val Ala Asp Arg Tyr Pro - # Ala Tyr Leu Gly Ser Ala AsnArg# 255- Val Ala Gln Lys Pro Ala Asn Glu - # Ala Leu Ala Gln Ala Asp ValVal# 270- Leu Phe Val Gly Asn Asn Tyr Pro - # Phe Ala Glu Val Ser Lys AlaPhe# 285- Lys Asn Thr Arg Tyr Phe Leu Gln - # Ile Asp Ile Asp Pro Ala LysLeu# 300- Gly Lys Arg His Lys Thr Asp Ile - # Ala Val Leu Ala Asp Ala GlnLys# 320- Thr Leu Ala Ala Ile Leu Ala Gln - # Val Ser Glu Arg Glu Ser ThrPro# 335- Trp Trp Gln Ala Asn Leu Ala Asn - # Val Lys Asn Trp Arg Ala TyrLeu# 350- Ala Ser Leu Glu Asp Lys Gln Glu - # Gly Pro Leu Gln Ala Tyr GlnVal# 365- Leu Arg Ala Val Asn Lys Ile Ala - # Glu Pro Asp Ala Ile Tyr SerIle# 380- Asp Val Gly Asp Ile Asn Leu Asn - # Ala Asn Arg His Leu Lys LeuThr# 400- Pro Ser Asn Arg His Ile Thr Ser - # Asn Leu Phe Ala Thr Met GlyVal# 415- Gly Ile Pro Gly Ala Ile Ala Ala - # Lys Leu Asn Tyr Pro Glu ArgGln# 430- Val Phe Asn Leu Ala Gly Asp Gly - # Gly Ala Ser Met Thr Met GlnAsp# 445- Leu Val Thr Gln Val Gln Tyr His - # Leu Pro Val Ile Asn Val ValPhe# 460- Thr Asn Cys Gln Tyr Gly Phe Ile - # Lys Asp Glu Gln Glu Asp ThrAsn# 480- Gln Asn Asp Phe Ile Gly Val Glu - # Phe Asn Asp Ile Asp Phe SerLys# 495- Ile Ala Asp Gly Val His Met Gln - # Ala Phe Arg Val Asn Lys IleGlu# 510- Gln Leu Pro Asp Val Phe Glu Gln - # Ala Lys Ala Ile Ala Gln HisGlu# 525- Pro Val Leu Ile Asp Ala Val Ile - # Thr Gly Asp Arg Pro Leu ProAla# 540- Glu Lys Leu Arg Leu Asp Ser Ala - # Met Ser Ser Ala Ala Asp IleGlu# 560- Ala Phe Lys Gln Arg Tyr Glu Ala - # Gln Asp Leu Gln Pro Leu SerThr# 575- Tyr Leu Lys Gln Phe Gly Leu Asp - # Asp# 585- (2) INFORMATION FOR SEQ ID NO:3:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 599 amino (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (iii) HYPOTHETICAL: NO- (iv) ANTI-SENSE: NO- (vi) ORIGINAL SOURCE: (A) ORGANISM: Zea mays- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:- Gly Ser Ala Ala Ser Pro Ala Met - # Pro Met Ala Pro Pro Ala ThrPro# 15- Leu Arg Pro Trp Gly Pro Thr Asp - # Pro Arg Lys Gly Ala Asp IleLeu# 30- Val Glu Ser Leu Glu Arg Cys Gly - # Val Arg Asp Val Phe Ala TyrPro# 45- Gly Gly Ala Ser Met Glu Ile His - # Gln Ala Leu Thr Arg Ser ProVal# 60- Ile Ala Asn His Leu Phe Arg His - # Glu Gln Gly Glu Ala Phe AlaAla# 80- Ser Gly Tyr Ala Arg Ser Ser Gly - # Arg Val Gly Val Cys Ile AlaThr# 95- Ser Gly Pro Gly Ala Thr Asn Leu - # Val Ser Ala Leu Ala Asp AlaLeu# 110- Leu Asp Ser Val Pro Met Val Ala - # Ile Thr Gly Gln Val Pro ArgArg# 125- Met Ile Gly Thr Asp Ala Phe Gln - # Glu Thr Pro Ile Val Glu ValThr# 140- Arg Ser Ile Thr Lys His Asn Tyr - # Leu Val Leu Asp Val Asp AspIle# 160- Pro Arg Val Val Gln Glu Ala Phe - # Phe Leu Ala Ser Ser Gly ArgPro# 175- Gly Pro Val Leu Val Asp Ile Pro - # Lys Asp Ile Gln Gln Gln MetAla# 190- Val Pro Val Trp Asp Lys Pro Met - # Ser Leu Pro Gly Tyr Ile AlaArg# 205- Leu Pro Lys Pro Pro Ala Thr Glu - # Leu Leu Glu Gln Val Leu ArgLeu# 220- Val Gly Glu Ser Arg Arg Pro Val - # Leu Tyr Val Gly Gly Gly CysAla# 240- Ala Ser Gly Glu Glu Leu Arg Arg - # Phe Val Glu Leu Thr Gly IlePro# 255- Val Thr Thr Thr Leu Met Gly Leu - # Gly Asn Phe Pro Ser Asp AspPro# 270- Leu Ser Leu Arg Met Leu Gly Met - # His Gly Thr Val Tyr Ala AsnTyr# 285- Ala Val Asp Lys Ala Asp Leu Leu - # Leu Ala Leu Gly Val Arg PheAsp# 300- Asp Arg Val Thr Gly Lys Ile Glu - # Ala Phe Ala Ser Arg Ala LysIle# 320- Val His Val Asp Ile Asp Pro Ala - # Glu Ile Gly Lys Asn Lys GlnPro# 335- His Val Ser Ile Cys Ala Asp Val - # Lys Leu Ala Leu Gln Gly MetAsn# 350- Ala Leu Leu Glu Gly Ser Thr Ser - # Lys Lys Ser Phe Asp Phe GlySer# 365- Trp Asn Asp Glu Leu Asp Gln Gln - # Lys Arg Glu Phe Pro Leu GlyTyr# 380- Lys Thr Ser Asn Glu Glu Ile Gln - # Pro Gln Tyr Ala Ile Gln ValLeu# 400- Asp Glu Leu Thr Lys Gly Glu Ala - # Ile Ile Gly Thr Gly Val GlyGln# 415- His Gln Met Trp Ala Ala Gln Tyr - # Tyr Thr Tyr Lys Arg Pro ArgGln# 430- Trp Leu Ser Ser Ala Gly Leu Gly - # Ala Met Gly Phe Gly Leu ProAla# 445- Ala Ala Gly Ala Ser Val Ala Asn - # Pro Gly Val Thr Val Val AspIle# 460- Asp Gly Asp Gly Ser Phe Leu Met - # Asn Val Gln Glu Leu Ala MetIle# 480- Arg Ile Glu Asn Leu Pro Val Lys - # Val Phe Val Leu Asn Asn GlnHis# 495- Leu Gly Met Val Val Gln Trp Glu - # Asp Arg Phe Tyr Lys Ala AsnArg# 510- Ala His Thr Tyr Leu Gly Asn Pro - # Glu Asn Glu Ser Glu Ile TyrPro# 525- Asp Phe Val Thr Ile Ala Lys Gly - # Phe Asn Ile Pro Ala Val ArgVal# 540- Thr Lys Lys Asn Glu Val Arg Ala - # Ala Ile Lys Lys Met Leu GluThr# 560- Pro Gly Pro Tyr Leu Leu Asp Ile - # Ile Val Pro His Gln Glu HisVal# 575- Leu Pro Met Ile Pro Ser Gly Gly - # Ala Phe Lys Asp Met Ile LeuAsp# 590- Gly Asp Gly Arg Thr Val Tyr 595- (2) INFORMATION FOR SEQ ID NO:4:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 638 amino (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (iii) HYPOTHETICAL: NO- (vi) ORIGINAL SOURCE: (A) ORGANISM: Zea mays- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:- Met Ala Thr Ala Ala Ala Ala Ser - # Thr Ala Leu Thr Gly Ala ThrThr# 15- Ala Ala Pro Lys Ala Arg Arg Arg - # Ala His Leu Leu Ala Thr ArgArg# 30- Ala Leu Ala Ala Pro Ile Arg Cys - # Ser Ala Ala Ser Pro Ala MetPro# 45- Met Ala Pro Pro Ala Thr Pro Leu - # Arg Pro Trp Gly Pro Thr AspPro# 60- Arg Lys Gly Ala Asp Ile Leu Val - # Glu Ser Leu Glu Arg Cys GlyVal# 80- Arg Asp Val Phe Ala Tyr Pro Gly - # Gly Ala Ser Met Glu Ile HisGln# 95- Ala Leu Thr Arg Ser Pro Val Ile - # Ala Asn His Leu Phe Arg HisGlu# 110- Gln Gly Glu Ala Phe Ala Ala Ser - # Gly Tyr Ala Arg Ser Ser GlyArg# 125- Val Gly Val Cys Ile Ala Thr Ser - # Gly Pro Gly Ala Thr Asn LeuVal# 140- Ser Ala Leu Ala Asp Ala Leu Leu - # Asp Ser Val Pro Met Val AlaIle# 160- Thr Gly Gln Val Pro Arg Arg Met - # Ile Gly Thr Asp Ala Phe GlnGlu# 175- Thr Pro Ile Val Glu Val Thr Arg - # Ser Ile Thr Lys His Asn TyrLeu# 190- Val Leu Asp Val Asp Asp Ile Pro - # Arg Val Val Gln Glu Ala PhePhe# 205- Leu Ala Ser Ser Gly Arg Pro Gly - # Pro Val Leu Val Asp Ile ProLys# 220- Asp Ile Gln Gln Gln Met Ala Val - # Pro Val Trp Asp Lys Pro MetSer# 240- Leu Pro Gly Tyr Ile Ala Arg Leu - # Pro Lys Pro Pro Ala Thr GluLeu# 255- Leu Glu Gln Val Leu Arg Leu Val - # Gly Glu Ser Arg Arg Pro ValLeu# 270- Tyr Val Gly Gly Gly Cys Ala Ala - # Ser Gly Glu Glu Leu Arg ArgPhe# 285- Val Glu Leu Thr Gly Ile Pro Val - # Thr Thr Thr Leu Met Gly LeuGly# 300- Asn Phe Pro Ser Asp Asp Pro Leu - # Ser Leu Arg Met Leu Gly MetHis# 320- Gly Thr Val Tyr Ala Asn Tyr Ala - # Val Asp Lys Ala Asp Leu LeuLeu# 335- Ala Leu Gly Val Arg Phe Asp Asp - # Arg Val Thr Gly Lys Ile GluAla# 350- Phe Ala Ser Arg Ala Lys Ile Val - # His Val Asp Ile Asp Pro AlaGlu# 365- Ile Gly Lys Asn Lys Gln Pro His - # Val Ser Ile Cys Ala Asp ValLys# 380- Leu Ala Leu Gln Gly Met Asn Ala - # Leu Leu Glu Gly Ser Thr SerLys# 400- Lys Ser Phe Asp Phe Gly Ser Trp - # Asn Asp Glu Leu Asp Gln GlnLys# 415- Arg Glu Phe Pro Leu Gly Tyr Lys - # Thr Ser Asn Glu Glu Ile GlnPro# 430- Gln Tyr Ala Ile Gln Val Leu Asp - # Glu Leu Thr Lys Gly Glu AlaIle# 445- Ile Gly Thr Gly Val Gly Gln His - # Gln Met Trp Ala Ala Gln TyrTyr# 460- Thr Tyr Lys Arg Pro Arg Gln Trp - # Leu Ser Ser Ala Gly Leu GlyAla# 480- Met Gly Phe Gly Leu Pro Ala Ala - # Ala Gly Ala Ser Val Ala AsnPro# 495- Gly Val Thr Val Val Asp Ile Asp - # Gly Asp Gly Ser Phe Leu MetAsn# 510- Val Gln Glu Leu Ala Met Ile Arg - # Ile Glu Asn Leu Pro Val LysVal# 525- Phe Val Leu Asn Asn Gln His Leu - # Gly Met Val Val Gln Trp GluAsp# 540- Arg Phe Tyr Lys Ala Asn Arg Ala - # His Thr Tyr Leu Gly Asn ProGlu# 560- Asn Glu Ser Glu Ile Tyr Pro Asp - # Phe Val Thr Ile Ala Lys GlyPhe# 575- Asn Ile Pro Ala Val Arg Val Thr - # Lys Lys Asn Glu Val Arg AlaAla# 590- Ile Lys Lys Met Leu Glu Thr Pro - # Gly Pro Tyr Leu Leu Asp IleIle# 605- Val Pro His Gln Glu His Val Leu - # Pro Met Ile Pro Ser Gly GlyAla# 620- Phe Lys Asp Met Ile Leu Asp Gly - # Asp Gly Arg Thr Val Tyr# 635- (2) INFORMATION FOR SEQ ID NO:5:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 638 amino (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (iii) HYPOTHETICAL: NO- (vi) ORIGINAL SOURCE: (A) ORGANISM: Zea mays- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:- Met Ala Thr Ala Ala Thr Ala Ala - # Ala Ala Leu Thr Gly Ala ThrThr# 15- Ala Thr Pro Lys Ser Arg Arg Arg - # Ala His His Leu Ala Thr ArgArg# 30- Ala Leu Ala Ala Pro Ile Arg Cys - # Ser Ala Leu Ser Arg Ala ThrPro# 45- Thr Ala Pro Pro Ala Thr Pro Leu - # Arg Pro Trp Gly Pro Asn GluPro# 60- Arg Lys Gly Ser Asp Ile Leu Val - # Glu Ala Leu Glu Arg Cys GlyVal# 80- Arg Asp Val Phe Ala Tyr Pro Gly - # Gly Ala Ser Met Glu Ile HisGln# 95- Ala Leu Thr Arg Ser Pro Val Ile - # Ala Asn His Leu Phe Arg HisGlu# 110- Gln Gly Glu Ala Phe Ala Ala Ser - # Ala Tyr Ala Arg Ser Ser GlyArg# 125- Val Gly Val Cys Ile Ala Thr Ser - # Gly Pro Gly Ala Thr Asn LeuVal# 140- Ser Ala Leu Ala Asp Ala Leu Leu - # Asp Ser Val Pro Met Val AlaIle# 160- Thr Gly Gln Val Pro Arg Arg Met - # Ile Gly Thr Asp Ala Phe GlnGlu# 175- Thr Pro Ile Val Glu Val Thr Arg - # Ser Ile Thr Lys His Asn TyrLeu# 190- Val Leu Asp Val Asp Asp Ile Pro - # Arg Val Val Gln Glu Ala PhePhe# 205- Leu Ala Ser Ser Gly Arg Pro Gly - # Pro Val Leu Val Asp Ile ProLys# 220- Asp Ile Gln Gln Gln Met Ala Val - # Pro Ala Trp Asp Thr Pro MetSer# 240- Leu Pro Gly Tyr Ile Ala Arg Leu - # Pro Lys Pro Pro Ala Thr GluPhe# 255- Leu Glu Gln Val Leu Arg Leu Val - # Gly Glu Ser Arg Arg Pro ValLeu# 270- Tyr Val Gly Gly Gly Cys Ala Ala - # Ser Gly Glu Glu Leu Cys ArgPhe# 285- Val Glu Leu Thr Gly Ile Pro Val - # Thr Thr Thr Leu Met Gly LeuGly# 300- Asn Phe Pro Ser Asp Asp Pro Leu - # Ser Leu Arg Met Leu Gly MetHis# 320- Gly Thr Val Tyr Ala Asn Tyr Ala - # Val Asp Lys Ala Asp Leu LeuLeu# 335- Ala Phe Gly Val Arg Phe Asp Asp - # Arg Val Thr Gly Lys Ile GluAla# 350- Phe Ala Gly Arg Ala Lys Ile Val - # His Ile Asp Ile Asp Pro AlaGlu# 365- Ile Gly Lys Asn Lys Gln Pro His - # Val Ser Ile Cys Ala Asp ValLys# 380- Leu Ala Leu Gln Gly Met Asn Thr - # Leu Leu Glu Gly Ser Thr SerLys# 400- Lys Ser Phe Asp Phe Gly Ser Trp - # His Asp Glu Leu Asp Gln GlnLys# 415- Arg Glu Phe Pro Leu Gly Tyr Lys - # Ile Phe Asn Glu Glu Ile GlnPro# 430- Gln Tyr Ala Ile Gln Val Leu Asp - # Glu Leu Thr Lys Gly Glu AlaIle# 445- Ile Ala Thr Gly Val Gly Gln His - # Gln Met Trp Ala Ala Gln TyrTyr# 460- Thr Tyr Lys Arg Pro Arg Gln Trp - # Leu Ser Ser Ala Gly Leu GlyAla# 480- Met Gly Phe Gly Leu Pro Ala Ala - # Ala Gly Ala Ala Val Ala AsnPro# 495- Gly Val Thr Val Val Asp Ile Asp - # Gly Asp Gly Ser Phe Leu MetAsn# 510- Ile Gln Glu Leu Ala Met Ile Arg - # Ile Glu Asn Leu Pro Val LysVal# 525- Phe Val Leu Asn Asn Gln His Leu - # Gly Met Val Val Gln Trp GluAsp# 540- Arg Phe Tyr Lys Ala Asn Arg Ala - # His Thr Phe Leu Gly Asn ProGlu# 560- Asn Glu Ser Glu Ile Tyr Pro Asp - # Phe Val Ala Ile Ala Lys GlyPhe# 575- Asn Ile Pro Ala Val Arg Val Thr - # Lys Lys Ser Glu Val His AlaAla# 590- Ile Lys Lys Met Leu Glu Ala Pro - # Gly Pro Tyr Leu Leu Asp IleIle# 605- Val Pro His Gln Glu His Val Leu - # Pro Met Ile Pro Ser Gly GlyAla# 620- Phe Lys Asp Met Ile Leu Asp Gly - # Asp Gly Arg Thr Val Tyr# 635- (2) INFORMATION FOR SEQ ID NO:6:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 667 amino (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (iii) HYPOTHETICAL: NO- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:- Met Ala Ala Ala Ala Pro Ser Pro - # Ser Ser Ser Ala Phe Ser LysThr# 15- Leu Ser Pro Ser Ser Ser Thr Ser - # Ser Thr Leu Leu Pro Arg SerThr# 30- Phe Pro Phe Pro His His Pro His - # Lys Thr Thr Pro Pro Pro LeuHis# 45- Leu Thr His Thr His Ile His Ile - # His Ser Gln Arg Arg Arg PheThr# 60- Ile Ser Asn Val Ile Ser Thr Asn - # Gln Lys Val Ser Gln Thr GluLys# 80- Thr Glu Thr Phe Val Ser Arg Phe - # Ala Pro Asp Glu Pro Arg LysGly# 95- Ser Asp Val Leu Val Glu Ala Leu - # Glu Arg Glu Gly Val Thr AspVal# 110- Phe Ala Tyr Pro Gly Gly Ala Ser - # Met Glu Ile His Gln Ala LeuThr# 125- Arg Ser Ser Ile Ile Arg Asn Val - # Leu Pro Arg His Glu Gln GlyGly# 140- Val Phe Ala Ala Glu Gly Tyr Ala - # Arg Ala Thr Gly Phe Pro GlyVal# 160- Cys Ile Ala Thr Ser Gly Pro Gly - # Ala Thr Asn Leu Val Ser GlyLeu# 175- Ala Asp Ala Leu Leu Asp Ser Val - # Pro Ile Val Ala Ile Thr GlyGln# 190- Val Pro Arg Arg Met Ile Gly Thr - # Asp Ala Phe Gln Glu Thr ProIle# 205- Val Glu Val Thr Arg Ser Ile Thr - # Lys His Asn Tyr Leu Val MetAsp# 220- Val Glu Asp Ile Pro Arg Val Val - # Arg Glu Ala Phe Phe Leu AlaArg# 240- Ser Gly Arg Pro Gly Pro Ile Leu - # Ile Asp Val Pro Lys Asp IleGln# 255- Gln Gln Leu Val Ile Pro Asp Trp - # Asp Gln Pro Met Arg Leu ProGly# 270- Tyr Met Ser Arg Leu Pro Lys Leu - # Pro Asn Glu Met Leu Leu GluGln# 285- Ile Val Arg Leu Ile Ser Glu Ser - # Lys Lys Pro Val Leu Tyr ValGly# 300- Gly Gly Cys Ser Gln Ser Ser Glu - # Asp Leu Arg Arg Phe Val GluLeu# 320- Thr Gly Ile Pro Val Ala Ser Thr - # Leu Met Gly Leu Gly Ala PhePro# 335- Thr Gly Asp Glu Leu Ser Leu Ser - # Met Leu Gly Met His Gly ThrVal# 350- Tyr Ala Asn Tyr Ala Val Asp Ser - # Ser Asp Leu Leu Leu Ala PheGly# 365- Val Arg Phe Asp Asp Arg Val Thr - # Gly Lys Leu Glu Ala Phe AlaSer# 380- Arg Ala Lys Ile Val His Ile Asp - # Ile Asp Ser Ala Glu Ile GlyLys# 400- Asn Lys Gln Pro His Val Ser Ile - # Cys Ala Asp Ile Lys Leu AlaLeu# 415- Gln Gly Leu Asn Ser Ile Leu Glu - # Ser Lys Glu Gly Lys Leu LysLeu# 430- Asp Phe Ser Ala Trp Arg Gln Glu - # Leu Thr Glu Gln Lys Val LysHis# 445- Pro Leu Asn Phe Lys Thr Phe Gly - # Asp Ala Ile Pro Pro Gln TyrAla# 460- Ile Gln Val Leu Asp Glu Leu Thr - # Asn Gly Asn Ala Ile Ile SerThr# 480- Gly Val Gly Gln His Gln Met Trp - # Ala Ala Gln Tyr Tyr Lys TyrArg# 495- Lys Pro Arg Gln Trp Leu Thr Ser - # Gly Gly Leu Gly Ala Met GlyPhe# 510- Gly Leu Pro Ala Ala Ile Gly Ala - # Ala Val Gly Arg Pro Asp GluVal# 525- Val Val Asp Ile Asp Gly Asp Gly - # Ser Phe Ile Met Asn Val GlnGlu# 540- Leu Ala Thr Ile Lys Val Glu Asn - # Leu Pro Val Lys Ile Met LeuLeu# 560- Asn Asn Gln His Leu Gly Met Val - # Val Gln Trp Glu Asp Arg PheTyr# 575- Lys Ala Asn Arg Ala His Thr Tyr - # Leu Gly Asn Pro Ser Asn GluAla# 590- Glu Ile Phe Pro Asn Met Leu Lys - # Phe Ala Glu Ala Cys Gly ValPro# 605- Ala Ala Arg Val Thr His Arg Asp - # Asp Leu Arg Ala Ala Ile GlnLys# 620- Met Leu Asp Thr Pro Gly Pro Tyr - # Leu Leu Asp Val Ile Val ProHis# 640- Gln Glu His Val Leu Pro Met Ile - # Pro Ser Gly Gly Ala Phe LysAsp# 655- Val Ile Thr Glu Gly Asp Gly Arg - # Ser Ser Tyr# 665- (2) INFORMATION FOR SEQ ID NO:7:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 664 amino (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:- Met Ala Ala Ala Ala Ala Ala Pro - # Ser Pro Ser Phe Ser Lys ThrLeu# 15- Ser Ser Ser Ser Ser Lys Ser Ser - # Thr Leu Leu Pro Arg Ser ThrPhe# 30- Pro Phe Pro His His Pro His Lys - # Thr Thr Pro Pro Pro Leu HisLeu# 45- Thr Pro Thr His Ile His Ser Gln - # Arg Arg Arg Phe Thr Ile SerAsn# 60- Val Ile Ser Thr Thr Gln Lys Val - # Ser Glu Thr Gln Lys Ala GluThr# 80- Phe Val Ser Arg Phe Ala Pro Asp - # Glu Pro Arg Lys Gly Ser AspVal# 95- Leu Val Glu Ala Leu Glu Arg Glu - # Gly Val Thr Asp Val Phe AlaTyr# 110- Pro Gly Gly Ala Ser Met Glu Ile - # His Gln Ala Leu Thr Arg SerSer# 125- Ile Ile Arg Asn Val Leu Pro Arg - # His Glu Gln Gly Gly Val PheAla# 140- Ala Glu Gly Tyr Ala Arg Ala Thr - # Gly Phe Pro Gly Val Cys IleAla# 160- Thr Ser Gly Pro Gly Ala Thr Asn - # Leu Val Ser Gly Leu Ala AspAla# 175- Leu Leu Asp Ser Val Pro Ile Val - # Ala Ile Thr Gly Gln Val ProArg# 190- Arg Met Ile Gly Thr Asp Ala Phe - # Gln Glu Thr Pro Ile Val GluVal# 205- Thr Arg Ser Ile Thr Lys His Asn - # Tyr Leu Val Met Asp Val GluAsp# 220- Ile Pro Arg Val Val Arg Glu Ala - # Phe Phe Leu Ala Arg Ser GlyArg# 240- Pro Gly Pro Val Leu Ile Asp Val - # Pro Lys Asp Ile Gln Gln GlnLeu# 255- Val Ile Pro Asp Trp Asp Gln Pro - # Met Arg Leu Pro Gly Tyr MetSer# 270- Arg Leu Pro Lys Leu Pro Asn Glu - # Met Leu Leu Glu Gln Ile ValArg# 285- Leu Ile Ser Glu Ser Lys Lys Pro - # Val Leu Tyr Val Gly Gly GlyCys# 300- Ser Gln Ser Ser Glu Glu Leu Arg - # Arg Phe Val Glu Leu Thr GlyIle# 320- Pro Val Ala Ser Thr Leu Met Gly - # Leu Gly Ala Phe Pro Thr GlyAsp# 335- Glu Leu Ser Leu Ser Met Leu Gly - # Met His Gly Thr Val Tyr AlaAsn# 350- Tyr Ala Val Asp Ser Ser Asp Leu - # Leu Leu Ala Phe Gly Val ArgPhe# 365- Asp Asp Arg Val Thr Gly Lys Leu - # Glu Ala Phe Ala Ser Arg AlaLys# 380- Ile Val His Ile Asp Ile Asp Ser - # Ala Glu Ile Gly Lys Asn LysGln# 400- Pro His Val Ser Ile Cys Ala Asp - # Ile Lys Leu Ala Leu Gln GlyLeu# 415- Asn Ser Ile Leu Glu Ser Lys Glu - # Gly Lys Leu Lys Leu Asp PheSer# 430- Ala Trp Arg Gln Glu Leu Thr Val - # Gln Lys Val Lys Tyr Pro LeuAsn# 445- Phe Lys Thr Phe Gly Asp Ala Ile - # Pro Pro Gln Tyr Ala Ile GlnVal# 460- Leu Asp Glu Leu Thr Asn Gly Ser - # Ala Ile Ile Ser Thr Gly ValGly# 480- Gln His Gln Met Trp Ala Ala Gln - # Tyr Tyr Lys Tyr Arg Lys ProArg# 495- Gln Trp Leu Thr Ser Gly Gly Leu - # Gly Ala Met Gly Phe Gly LeuPro# 510- Ala Ala Ile Gly Ala Ala Val Gly - # Arg Pro Asp Glu Val Val ValAsp# 525- Ile Asp Gly Asp Gly Ser Phe Ile - # Met Asn Val Gln Glu Leu AlaThr# 540- Ile Lys Val Glu Asn Leu Pro Val - # Lys Ile Met Leu Leu Asn AsnGln# 560- His Leu Gly Met Val Val Gln Trp - # Glu Asp Arg Phe Tyr Lys AlaAsn# 575- Arg Ala His Thr Tyr Leu Gly Asn - # Pro Ser Asn Glu Ala Glu IlePhe# 590- Pro Asn Met Leu Lys Phe Ala Glu - # Ala Cys Gly Val Pro Ala AlaArg# 605- Val Thr His Arg Asp Asp Leu Arg - # Ala Ala Ile Gln Lys Met LeuAsp# 620- Thr Pro Gly Pro Tyr Leu Leu Asp - # Val Ile Val Pro His Gln GluHis# 640- Val Leu Pro Met Ile Pro Ser Gly - # Gly Ala Phe Lys Asp Val IleThr# 655- Glu Gly Asp Gly Arg Ser Ser Tyr 660- (2) INFORMATION FOR SEQ ID NO:8:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 671 amino (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (iii) HYPOTHETICAL: NO- (vi) ORIGINAL SOURCE:#thaliana (A) ORGANISM: Arabidopsis- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:- Met Ala Ala Ala Thr Thr Thr Thr - # Thr Thr Ser Ser Ser Ile SerPhe# 15- Ser Thr Lys Pro Ser Pro Ser Ser - # Ser Lys Ser Pro Leu Pro IleSer# 30- Arg Phe Ser Leu Pro Phe Ser Leu - # Asn Pro Asn Lys Ser Ser SerSer# 45- Ser Arg Arg Arg Gly Ile Lys Ser - # Ser Ser Pro Ser Ser Ile SerAla# 60- Val Leu Asn Thr Thr Thr Asn Val - # Thr Thr Thr Pro Ser Pro ThrLys# 80- Pro Thr Lys Pro Glu Thr Phe Ile - # Ser Arg Phe Ala Pro Asp GlnPro# 95- Arg Lys Gly Ala Asp Ile Leu Val - # Glu Ala Leu Glu Arg Gln GlyVal# 110- Glu Thr Val Phe Ala Tyr Pro Gly - # Gly Ala Ser Met Glu Ile HisGln# 125- Ala Leu Thr Arg Ser Ser Ser Ile - # Arg Asn Val Leu Pro Arg HisGlu# 140- Gln Gly Gly Val Phe Ala Ala Glu - # Gly Tyr Ala Arg Ser Ser GlyLys# 160- Pro Gly Ile Cys Ile Ala Thr Ser - # Gly Pro Gly Ala Thr Asn LeuVal# 175- Ser Gly Leu Ala Asp Ala Leu Leu - # Asp Ser Val Pro Leu Val AlaIle# 190- Thr Gly Gln Val Pro Arg Arg Met - # Ile Gly Thr Asp Ala Phe GlnGlu# 205- Thr Pro Ile Val Glu Val Thr Arg - # Ser Ile Thr Lys His Asn TyrLeu# 220- Val Met Asp Val Glu Asp Ile Pro - # Arg Ile Ile Glu Glu Ala PhePhe# 240- Leu Ala Thr Ser Gly Arg Pro Gly - # Pro Val Leu Val Asp Val ProLys# 255- Asp Ile Gln Gln Gln Leu Ala Ile - # Pro Asn Trp Glu Gln Ala MetArg# 270- Leu Pro Gly Tyr Met Ser Arg Met - # Pro Lys Pro Pro Glu Asp SerHis# 285- Leu Glu Gln Ile Val Arg Leu Ile - # Ser Glu Ser Lys Lys Pro ValLeu# 300- Tyr Val Gly Gly Gly Cys Leu Asn - # Ser Ser Asp Glu Leu Gly ArgPhe# 320- Val Glu Leu Thr Gly Ile Pro Val - # Ala Ser Thr Leu Met Gly LeuGly# 335- Ser Tyr Pro Cys Asp Asp Glu Leu - # Ser Leu His Met Leu Gly MetHis# 350- Gly Thr Val Tyr Ala Asn Tyr Ala - # Val Glu His Ser Asp Leu LeuLeu# 365- Ala Phe Gly Val Arg Phe Asp Asp - # Arg Val Thr Gly Lys Leu GluAla# 380- Phe Ala Ser Arg Ala Lys Ile Val - # His Ile Asp Ile Asp Ser AlaGlu# 400- Ile Gly Lys Asn Lys Thr Pro His - # Val Ser Val Cys Gly Asp ValLys# 415- Leu Ala Leu Gln Gly Met Asn Lys - # Val Leu Glu Asn Arg Ala GluGlu# 430- Leu Lys Leu Asp Phe Gly Val Trp - # Arg Asn Glu Leu Asn Val GlnLys# 445- Gln Lys Phe Pro Leu Ser Phe Lys - # Thr Phe Gly Glu Ala Ile ProPro# 460- Gln Tyr Ala Ile Lys Val Leu Asp - # Glu Leu Thr Asp Gly Lys AlaIle# 480- Ile Ser Thr Gly Val Gly Gln His - # Gln Met Trp Ala Ala Gln PheTyr# 495- Asn Tyr Lys Lys Pro Arg Arg Gln - # Trp Leu Ser Ser Gly Gly LeuGly# 510- Ala Met Gly Phe Gly Leu Pro Ala - # Ala Ile Gly Ala Ser Val AlaAsn# 525- Pro Asp Ala Ile Val Val Asp Ile - # Asp Gly Asp Gly Ser Phe IleMet# 540- Asn Val Gln Glu Leu Ala Thr Ile - # Arg Val Glu Asn Leu Pro ValLys# 560- Val Leu Leu Leu Asn Asn Gln His - # Leu Gly Met Val Met Gln TrpGlu# 575- Asp Arg Phe Tyr Lys Ala Asn Arg - # Ala His Thr Phe Leu Gly AspPro# 590- Ala Gln Glu Asp Glu Ile Phe Pro - # Asn Met Leu Leu Phe Ala AlaAla# 605- Cys Gly Ile Pro Ala Ala Arg Val - # Thr Lys Lys Ala Asp Leu ArgGlu# 620- Ala Ile Gln Thr Met Leu Asp Thr - # Pro Gly Pro Tyr Leu Leu AspVal# 640- Ile Cys Pro His Gln Glu His Val - # Leu Pro Met Ile Pro Asn GlyGly# 655- Thr Phe Asn Asp Val Ile Thr Glu - # Gly Asp Gly Arg Ile Lys Tyr# 670- (2) INFORMATION FOR SEQ ID NO:9:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 652 amino (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (iii) HYPOTHETICAL: NO- (vi) ORIGINAL SOURCE:#napus (A) ORGANISM: Brassica- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:- Met Ala Ala Ala Thr Ser Ser Ser - # Pro Ile Ser Leu Thr Ala LysPro# 15- Ser Ser Lys Ser Pro Leu Pro Ile - # Ser Arg Phe Ser Leu Pro PheSer# 30- Leu Thr Pro Gln Lys Pro Ser Ser - # Arg Leu His Arg Pro Leu AlaIle# 45- Ser Ala Val Leu Asn Ser Pro Val - # Asn Val Ala Pro Glu Lys ThrAsp# 60- Lys Ile Lys Thr Phe Ile Ser Arg - # Tyr Ala Pro Asp Glu Pro ArgLys# 80- Gly Ala Asp Ile Leu Val Glu Ala - # Leu Glu Arg Gln Gly Val GluThr# 95- Val Phe Ala Tyr Pro Gly Gly Ala - # Ser Met Glu Ile His Gln AlaLeu# 110- Thr Arg Ser Ser Thr Ile Arg Asn - # Val Leu Pro Arg His Glu GlnGly# 125- Gly Val Phe Ala Ala Glu Gly Tyr - # Ala Arg Ser Ser Gly Lys ProGly# 140- Ile Cys Ile Ala Thr Ser Gly Pro - # Gly Ala Thr Asn Leu Val SerGly# 160- Leu Ala Asp Ala Met Leu Asp Ser - # Val Pro Leu Val Ala Ile ThrGly# 175- Gln Val Pro Arg Arg Met Ile Gly - # Thr Asp Ala Phe Gln Glu ThrPro# 190- Ile Val Glu Val Thr Arg Ser Ile - # Thr Lys His Asn Tyr Leu ValMet# 205- Asp Val Asp Asp Ile Pro Arg Ile - # Val Gln Glu Ala Phe Phe LeuAla# 220- Thr Ser Gly Arg Pro Gly Pro Val - # Leu Val Asp Val Pro Lys AspIle# 240- Gln Gln Gln Leu Ala Ile Pro Asn - # Trp Asp Gln Pro Met Arg LeuPro# 255- Gly Tyr Met Ser Arg Leu Pro Gln - # Pro Pro Glu Val Ser Gln LeuGly# 270- Gln Ile Val Arg Leu Ile Ser Glu - # Ser Lys Arg Pro Val Leu TyrVal# 285- Gly Gly Gly Ser Leu Asn Ser Ser - # Glu Glu Leu Gly Arg Phe ValGlu# 300- Leu Thr Gly Ile Pro Val Ala Ser - # Thr Leu Met Gly Leu Gly SerTyr# 320- Pro Cys Asn Asp Glu Leu Ser Leu - # Gln Met Leu Gly Met His GlyThr# 335- Val Tyr Ala Asn Tyr Ala Val Glu - # His Ser Asp Leu Leu Leu AlaPhe# 350- Gly Val Arg Phe Asp Asp Arg Val - # Thr Gly Lys Leu Glu Ala PheAla# 365- Ser Arg Ala Lys Ile Val His Ile - # Asp Ile Asp Ser Ala Glu IleGly# 380- Lys Asn Lys Thr Pro His Val Ser - # Val Cys Gly Asp Val Lys LeuAla# 400- Leu Gln Gly Met Asn Lys Val Leu - # Glu Asn Arg Ala Glu Glu LeuLys# 415- Leu Asp Phe Gly Val Trp Arg Ser - # Glu Leu Ser Glu Gln Lys GlnLys# 430- Phe Pro Leu Ser Phe Lys Thr Phe - # Gly Glu Ala Ile Pro Pro GlnTyr# 445- Ala Ile Gln Val Leu Asp Glu Leu - # Thr Gln Gly Lys Ala Ile IleSer# 460- Thr Gly Val Gly Gln His Gln Met - # Trp Ala Ala Gln Phe Tyr LysTyr# 480- Arg Lys Pro Arg Gln Trp Leu Ser - # Ser Ser Gly Leu Gly Ala MetGly# 495- Phe Gly Leu Pro Ala Ala Ile Gly - # Ala Ser Val Ala Asn Pro AspAla# 510- Ile Val Val Asp Ile Asp Gly Asp - # Gly Ser Phe Ile Met Asn ValGln# 525- Glu Leu Ala Thr Ile Arg Val Glu - # Asn Leu Pro Val Lys Ile LeuLeu# 540- Leu Asn Asn Gln His Leu Gly Met - # Val Met Gln Trp Glu Asp ArgPhe# 560- Tyr Lys Ala Asn Arg Ala His Thr - # Tyr Leu Gly Asp Pro Ala ArgGlu# 575- Asn Glu Ile Phe Pro Asn Met Leu - # Gln Phe Ala Gly Ala Cys GlyIle# 590- Pro Ala Ala Arg Val Thr Lys Lys - # Glu Glu Leu Arg Glu Ala IleGln# 605- Thr Met Leu Asp Thr Pro Gly Pro - # Tyr Leu Leu Asp Val Ile CysPro# 620- His Gln Glu His Val Leu Pro Met - # Ile Pro Ser Gly Gly Thr PheLys# 640- Asp Val Ile Thr Glu Gly Asp Gly - # Arg Thr Lys Tyr# 650- (2) INFORMATION FOR SEQ ID NO:10:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 637 amino (B) TYPE: amino acid (C) STRANDEDNESS: (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein- (iii) HYPOTHETICAL: NO- (vi) ORIGINAL SOURCE:#napus (A) ORGANISM: Brassica- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:- Met Ala Ser Phe Ser Phe Phe Gly - # Thr Ile Pro Ser Ser Pro ThrLys# 15- Ala Ser Val Phe Ser Leu Pro Val - # Ser Val Thr Thr Leu Pro SerPhe# 30- Pro Arg Arg Arg Ala Thr Arg Val - # Ser Val Ser Ala Asn Ser LysLys# 45- Asp Gln Asp Arg Thr Ala Ser Arg - # Arg Glu Asn Pro Ser Thr PheSer# 60- Ser Lys Tyr Ala Pro Asn Val Pro - # Arg Ser Gly Ala Asp Ile LeuVal# 80- Glu Ala Leu Glu Arg Gln Gly Val - # Asp Val Val Phe Ala Tyr ProGly# 95- Gly Ala Ser Met Glu Ile His Gln - # Ala Leu Thr Arg Ser Asn ThrIle# 110- Arg Asn Val Leu Pro Arg His Glu - # Gln Gly Gly Ile Phe Ala AlaGlu# 125- Gly Tyr Ala Arg Ser Ser Gly Lys - # Pro Gly Ile Cys Ile Ala ThrSer# 140- Gly Pro Gly Ala Met Asn Leu Val - # Ser Gly Leu Ala Asp Ala LeuPhe# 160- Asp Ser Val Pro Leu Ile Ala Ile - # Thr Gly Gln Val Pro Arg ArgMet# 175- Ile Gly Thr Met Ala Phe Gln Glu - # Thr Pro Val Val Glu Val ThrArg# 190- Thr Ile Thr Lys His Asn Tyr Leu - # Val Met Glu Val Asp Asp IlePro# 205- Arg Ile Val Arg Glu Ala Phe Phe - # Leu Ala Thr Ser Val Arg ProGly# 220- Pro Val Leu Ile Asp Val Pro Lys - # Asp Val Gln Gln Gln Phe AlaIle# 240- Pro Asn Trp Glu Gln Pro Met Arg - # Leu Pro Leu Tyr Met Ser ThrMet# 255- Pro Lys Pro Pro Lys Val Ser His - # Leu Glu Gln Ile Leu Arg LeuVal# 270- Ser Glu Ser Lys Arg Pro Val Leu - # Tyr Val Gly Gly Gly Cys LeuAsn# 285- Ser Ser Glu Glu Leu Arg Arg Phe - # Val Glu Leu Thr Gly Ile ProVal# 300- Ala Ser Thr Phe Met Gly Leu Gly - # Ser Tyr Pro Cys Asp Asp GluGlu# 320- Phe Ser Leu Gln Met Leu Gly Met - # His Gly Thr Val Tyr Ala AsnTyr# 335- Ala Val Glu Tyr Ser Asp Leu Leu - # Leu Ala Phe Gly Val Arg PheAsp# 350- Asp Arg Val Thr Gly Lys Leu Glu - # Ala Phe Ala Ser Arg Ala LysIle# 365- Val His Ile Asp Ile Asp Ser Thr - # Glu Ile Gly Lys Asn Lys ThrPro# 380- His Val Ser Val Cys Cys Asp Val - # Gln Leu Ala Leu Gln Gly MetAsn# 400- Glu Val Leu Glu Asn Arg Arg Asp - # Val Leu Asp Phe Gly Glu TrpArg# 415- Cys Glu Leu Asn Glu Gln Arg Leu - # Lys Phe Pro Leu Arg Tyr LysThr# 430- Phe Gly Glu Glu Ile Pro Pro Gln - # Tyr Ala Ile Gln Leu Leu AspGlu# 445- Leu Thr Asp Gly Lys Ala Ile Ile - # Thr Thr Gly Val Gly Gln HisGln# 460- Met Trp Ala Ala Gln Phe Tyr Arg - # Phe Lys Lys Pro Arg Gln TrpLeu# 480- Ser Ser Gly Gly Leu Gly Ala Met - # Gly Phe Gly Leu Pro Ala AlaMet# 495- Gly Ala Ala Ile Ala Asn Pro Gly - # Ala Val Val Val Asp Ile AspGly# 510- Asp Gly Ser Phe Ile Met Asn Ile - # Gln Glu Leu Ala Thr Ile ArgVal# 525- Glu Asn Leu Pro Val Lys Val Leu - # Leu Ile Asn Asn Gln His LeuGly# 540- Met Val Leu Gln Trp Glu Asp His - # Phe Tyr Ala Ala Asn Arg AlaAsp# 560- Ser Phe Leu Gly Asp Pro Ala Asn - # Pro Glu Ala Val Phe Pro AspMet# 575- Leu Leu Phe Ala Ala Ser Cys Gly - # Ile Pro Ala Ala Arg Val ThrArg# 590- Arg Glu Asp Leu Arg Glu Ala Ile - # Gln Thr Met Leu Asp Thr ProGly# 605- Pro Phe Leu Leu Asp Val Val Cys - # Pro His Gln Asp His Val LeuPro# 620- Leu Ile Pro Ser Gly Gly Thr Phe - # Lys Asp Ile Ile Val# 635__________________________________________________________________________

Structure-based designed herbicide resistant products

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Abstract

Description

Claims

Parent Case Info

US Referenced Citations (1)

Non-Patent Literature Citations (14)

Divisions (1)

Entry
Mosimann et al. (1996), "A critical assessment of comparative molecular modeling of tertiary structure of protein" Proteins: Structure, Function and Genetics, 23 (3):301-317.
Blundell et al. (1987), "Knowledge-based prediction of protein structures and design of novel molecule", Nature 326:347-352.
Hattori et al. (1992), "Multiple resistance to sulfonylureas and imidazolinones conferred by acetohydroxyacid synthase gene with separate mutations for selective resistance", Mol. Gen. Genet., 232:167-173.
Yadav et al. (1986), "Single amino acid substitutions in the enzyme acetolactate synthase confer resistance to the herbicide sulfometuron methyl" Pro. Natl. Acad. Sci. USA, 83:4418-4422.
Bernasconi et al. (1995), "A naturally occurring point mutation confers broad range tolerance to herbicides that target acetolactate synthase", J. Biol. Chem., 270:17381-17385.
Sathasivan et al. (1990), "Nucleotide sequence of a mutant acetolactate synthase gene from an imidazolinone-resistant Arabidopsis thaliana var. Columbia", Nucl. Acids Res., 18:2188.
Bernasconi et al., Journal of Biological Chemistry, 270:17381-17385, 1995.
Blundell et al., Nature, 326:347-352, 1987.
Hattori et al., Mol Gen Genet., 232:167-173, 1992.
Haughn et al., Mol Gen Genet., 204:430-434, 1986.
Mosimann et al., Proteins, 23:301-317, 1995.
Sathasiva et al., Nucleic Acids Research, 18:2188, 1990.
Stidham, Weed Science, 39:428-434, 1991.
Yadav et al., Proc. Nat'l. Acad. Sci., USA, 83:4418-4422, 1986.